31/2023. (VIII. 22.) BM rendelet
az ellenőrzött anyagokról szóló 78/2022. (XII. 28.) BM rendelet módosításáról
Az emberi alkalmazásra kerülő gyógyszerekről és egyéb, a gyógyszerpiacot szabályozó törvények módosításáról szóló 2005. évi XCV. törvény 32. § (5a) bekezdésében kapott felhatalmazás alapján, a Kormány tagjainak feladat- és hatásköréről szóló 182/2022. (V. 24.) Korm. rendelet 66. § (1) bekezdés 26. pontjában meghatározott feladatkörömben eljárva a következőket rendelem el:
1. § Az ellenőrzött anyagokról szóló 78/2022. (XII. 28.) BM rendelet (a továbbiakban: R.) a következő 4. §-sal egészül ki:
"4. § E rendelet tervezetének a műszaki szabályokkal és az információs társadalom szolgáltatásaira vonatkozó szabályokkal kapcsolatos információszolgáltatási eljárás megállapításáról szóló, 2015. szeptember 9-i (EU) 2015/1535 európai parlamenti és tanácsi irányelv 5-7. cikke szerinti előzetes bejelentése megtörtént."
2. § Az R. 1. melléklete helyébe az 1. melléklet lép.
3. § Az R. 2. melléklete helyébe a 2. melléklet lép.
4. § Az R. 3. melléklete a 3. melléklet szerint módosul.
5. § Ez a rendelet a kihirdetését követő 3. napon lép hatályba.
6. § E rendelet tervezetének a műszaki szabályokkal és az információs társadalom szolgáltatásaira vonatkozó szabályokkal kapcsolatos információszolgáltatási eljárás megállapításáról szóló, 2015. szeptember 9-i (EU) 2015/1535 európai parlamenti és tanácsi irányelv 5-7. cikke szerinti előzetes bejelentése megtörtént.
Dr. Pintér Sándor s. k.,
belügyminiszter
1. melléklet a31/2023. (VIII. 22.) BM rendelethez
"1. melléklet a 78/2022.(XII. 28.) BM rendelethez
KÁBÍTÓSZEREK JEGYZÉKEI
A kábítószerek e melléklet szerinti jegyzékeiben hivatalos elnevezésként a táblázatok A oszlopában a vegyület, anyag nemzetközi neve (International Non-proprietary Name, a továbbiakban: INN) szerepel. Az angol név vastagon szedve, a magyar név alatta zárójelben. Amennyiben egy adott vegyületnél vagy anyagnál az International Narcotic Control Board (a továbbiakban: INCB) által közzétett aktuális listán nem áll rendelkezésre INN, hivatalos névként ezen aktuális listán közzétett első egyéb elnevezés kerül átvezetésre. E melléklet táblázatai B oszlopában az INCB által közzétett egyéb elnevezések kerülnek feltüntetésre, vesszővel elválasztva. A K1 és K2 jegyzékek C oszlopában a kémiai név illetve dőlt betűvel a leírás, a kémiai névhez tartozó összegképlet a D oszlopban, az InChIKey kémiai azonosító az E oszlopban szerepel. A jegyzékbe sorolás szempontjából az A-C oszlopban található adatok irányadók, a D és E oszlop adatai a vegyületek számítógépes kereshetőségét biztosítják.
1. Kábítószerek 1. jegyzéke (K1 jegyzék)
1.1. Kábítószerek az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | 3-methylfentanyl* (3-metilfentanil) | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide | C23H30N2O | MLQRZXNZHAOCHQ-UHFFFAOYSA-N | |
| 3 | 3-methylthiofentanyl* (3-metiltiofentanil) | N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide | C21H28N2OS | SRARDYUHGVMEQI-UHFFFAOYSA-N | |
| 4 | 4-fluoroisobutyrfentanyl (4-fluoroizobutirfentanil) | 4-FIBF, pFIBF | N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-yl)isobutyramide | C23H29FN2O | OZDOSQNUJIXEOR- UHFFFAOYSA-N |
| 5 | Acetorphine* (acetorfin) | 3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endoethenooripavine (derivative of thebaine) | C27H35NO5 | LFYBMMHFJIAKFE- PMEKXCSPSA-N | |
| 6 | Acetyl-alpha-methylfentanyl* (acetil-alfa-metilfentanil) | N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide | C22H28N2O | OKTLVZBUKMRPLL-UHFFFAOYSA-N | |
| 7 | Acetylfentanyl* (acetilfentanil) | Desmethyl fentanyl (dezmetil fentanil) | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide | C21H26N2O | FYIUUQUPOKIKNI-UHFFFAOYSA-N |
| 8 | Acetylmethadol (acetilmetadol) | 3-acetoxy-6-dimethylamino-4,4-diphenylheptane | C23H31NO2 | XBMIVRRWGCYBTQ- UHFFFAOYSA-N | |
| 9 | Acryloylfentanyl (akrilfentanil) | Acrylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide | C22H26N2O | RFQNLMWUIJJEQF- UHFFFAOYSA-N |
| 10 | Alfentanil (alfentanil) | N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide | C21H32N6O3 | IDBPHNDTYPBSNI- UHFFFAOYSA-N | |
| 11 | Alphacetylmethadol (alfacetilmetadol) | α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane | C23H31NO2 | XBMIVRRWGCYBTQ- XMSQKQJNSA-N | |
| 12 | Alphameprodine (alfameprodin) | α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine | C17H25NO2 | ODEGQXRCQDVXSJ- WMLDXEAASA-N | |
| 13 | Alphamethadol (alfametadol) | α-6-dimethylamino-4,4-diphenyl-3-heptanol | C21H29NO | QIRAYNIFEOXSPW- YLJYHZDGSA-N | |
| 14 | Alpha-methylfentanyl* (alfa-metilfentanil) | N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide | C23H30N2O | NGTVDHYUFBKWID- UHFFFAOYSA-N | |
| 15 | Alpha-methylthiofentanyl* (alfa-metiltiofentanil) | N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide | C21H28N2OS | YPOXDUYRRSUFFG- UHFFFAOYSA-N | |
| 16 | Alphaprodine (alfaprodin) | α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine | C16H23NO2 | UVAZQQHAVMNMHE- CJNGLKHVSA-N | |
| 17 | Allylprodine (allilprodin) | 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine | C18H25NO2 | KGYFOSCXVAXULR- UHFFFAOYSA-N | |
| 18 | Anileridine (anileridin) | 1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester | C22H28N2O2 | LKYQ LAWM NBFNJT- UHFFFAOYSA-N | |
| 19 | Benzethidine (benzetidin) | 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester | C23H29NO3 | UVTBZAWTRVBTMK- UHFFFAOYSA-N | |
| 20 | Benzylmorphine (benzilmorfin) | 3-benzylmorphine | C24H25NO3 | RDJGWRFTDZZXSM- RNWLQCGYSA-N | |
| 21 | Betacetylmethadol (bétacetilmetadol) | β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane | C23H31NO2 | XBMIVRRWGCYBTQ- GCJKJVERSA-N |
| 22 | Beta-hydroxy-3-methylfentanyl* (béta-hidroxi-3-metilfentanil) | N-[1-(β-hydroxyphenethyl)-3-methyl-4piperidyl]propionanilide | C23H30N2O2 | FRPRNNRJTCONEC- UHFFFAOYSA-N | |
| 23 | Beta-hydroxyfentanyl* (béta-hidroxifentanil) | N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide | C22H28N2O2 | JEFVHLMGRUJLET- UHFFFAOYSA-N | |
| 24 | Betameprodine (bétameprodin) | β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine | C17H25NO2 | ODEGQXRCQ DVXSJ- RHSMWYFYSA-N | |
| 25 | Betamethadol (bétametadol) | β-6-dimethylamino-4,4-diphenyl-3-heptanol | C21H29NO | QIRAYNIFEOXSPW- XLIONFOSSA-N | |
| 26 | Betaprodine (bétaprodin) | β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine | C16H23NO2 | UVAZQQHAVMNMHE- CZUORRHYSA-N | |
| 27 | Bezitramide (bezitramid) | 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)-piperidine | C31H32N4O2 | FLKWNFFCSSJANB- UHFFFAOYSA-N | |
| 28 | Brorphine (brorfin) | 1-(1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl)-1,3-dihydro-2Hbenzimidazol-2-one | C20H22BrN3O | CNOFBGYRMCBVLO- UHFFFAOYSA-N | |
| 29 | Butyrfentanyl (butirfentanil) | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide | C23H30N2O | QQOMYEQLWQJRKK- UHFFFAOYSA-N | |
| 30 | Cannabis*, cannabis resin* and extracts and tinctures of cannabis (Kannabisz*, kannabisz-gyanta*, -extraktum és -tinktúra) | ||||
| 31 | Carfentanil* (karfentanil) | methyl 1-(2-phenylethyl)-4- [phenyl(propanoyl)amino]piperidine-4-carboxylate | C24H30N2O3 | YDSDEBIZUNNPOB- UHFFFAOYSA-N | |
| 32 | Clonitazene (klonitazén) | 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole | C20H23ClN4O2 | GPZLDQAEBHTMPG- UHFFFAOYSA-N | |
| 33 | Coca leaf (koka levél) | - | - | ||
| 34 | Cocaine (kokain) | methyl ester of benzoylecgonine | C17H21NO4 | ZPUCINDJVBIVPJ- LJISPDSOSA-N |
| 35 | Codoxime (kodoxim) | dihydrocodeinone-6-carboxymethyloxime | C20H24N2O5 | WKJYCUVUZIIMJA- HJWMAQEXSA-N | |
| 36 | Concentrate of poppy straw (mákszalma koncentrátum) | CPS | A mákszalma alkaloid tartalmának dúsítására irányuló feldolgozás során nyert, kereskedelmi forgalmazásra szánt anyag. | ||
| 37 | Crotonylfentanyl (krotonilfentanil) | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide | C23H28N2O | VDYXGPCGBKLRDA- XNWCZRBMSA-N | |
| 38 | Cyclopropyfentanyl (ciklopropilfentanil) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]cyclopropanecarboxamide | C23H28N2O | OIQSKDSKROTEMN- UHFFFAOYSA-N | |
| 39 | Desomorphine* (dezomorfin) | dihydrodeoxymorphine | C17H21NO2 | LNNWVNGFPYWNQE- GMIGKAJZSA-N | |
| 40 | Dextromoramide (dextromoramid) | (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine | C25H32N2O2 | INUNXTSAACVKJS- OAQYLSRUSA-N | |
| 41 | Diampromide (diampromid) | N-[2-(methylphenethylamino)-propyl]propionanilide | C21H28N2O | RXTHKWVSXOIHJS- UHFFFAOYSA-N | |
| 42 | Diethylthiambutene (dietiltiambutén) | 3-diethylamino-1,1-di-(2’-thienyl)-1-butene | C16H21NS2 | CBYWMRHUUVRIAF- UHFFFAOYSA-N | |
| 43 | Difenoxin (difenoxin) | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid | C28H28N2O2 | UFIVBRCCIRTJTN- UHFFFAOYSA-N | |
| 44 | Dihydroetorphine (dihidroetorfin) | 7,8-dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endoethanotetrahydrooripavine | C25H35NO4 | BRTSNYPDACNMIP- FAWZKKEFSA-N | |
| 45 | Dihydromorphine (dihidromorfin) | morfinszármazék | C17H21NO3 | IJVCSMSMFSCRME- KBQPJGBKSA-N | |
| 46 | Dimenoxadol (dimenoxadol) | 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate | C20H25NO3 | RHUWRJWFHUKVED- UHFFFAOYSA-N | |
| 47 | Dimepheptanol (dimefeptanol) | 6-dimethylamino-4,4-diphenyl-3-heptanol | C21H29NO | QIRAYNIFEOXS PW- UHFFFAOYSA-N |
| 48 | Dimethylthiambutene (dimetiltiambutén) | 3-dimethylamino-1,1-di-(2’-thienyl)-1-butene | C14H17NS2 | CANBGVXYBPOLRR- UHFFFAOYSA-N | |
| 49 | Dioxaphetyl butyrate (dioxafetil-butirát) | ethyl-4-morpholino-2,2-diphenylbutyrate | C22H27NO3 | LQGIXNQCOXNCRP- UHFFFAOYSA-N | |
| 50 | Diphenoxylate (difenoxilát) | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4carboxylic acid ethyl ester | C30H32N2O2 | HYPPXZBJBPSRLK- UHFFFAOYSA-N | |
| 51 | Dipipanone (dipipanon) | 4,4-diphenyl-6-piperidine-3-heptanone | C24H31NO | SVDHSZFEQYXRDC- UHFFFAOYSA-N | |
| 52 | Drotebanol (drotebanol) | 3,4-dimethoxy-17-methylmorphinan-6β,14-diol | C19H27NO4 | LCAHPIFLPICNRW- SVYNMNNPSA-N | |
| 53 | Ecgonine (ekgonin) | ennek észterei és derivátumai, amelyek ekgoninná és kokainná alakíthatóak | C9H15NO3 | PHMBVCPLDPDESM- UHFFFAOYSA-N | |
| 54 | Ethylmethylthiambutene (etilmetiltiambutén) | 3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene | C15H19NS2 | MORSAEFGQPDBKM- UHFFFAOYSA-N | |
| 55 | Etonitazene (etonitazén) | 1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole | C22H28N4O3 | PXDBZSCGSQSKST- UHFFFAOYSA-N | |
| 56 | Etorphine* (etorfin) | tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endoethenooripavine | C25H33NO4 | CAHCBJPUTCKATP- UHFFFAOYSA-N | |
| 57 | Etoxeridine (etoxeridin) | 1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester | C18H27NO4 | KJTKYGFGPQSRRA- UHFFFAOYSA-N | |
| 58 | Fentanyl (fentanil) | 1-phenethyl-4-N-propionylanilinopiperidine | C22H28N2O | PJMPHNIQZUBGLI- UHFFFAOYSA-N | |
| 59 | Furanylfentanil (furanilfentanil) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2carboxamide | C24H26N2O2 | FZJVHWISUGFFQV- UHFFFAOYSA-N | |
| 60 | Furethidine (furetidin) | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4carboxylic acid ethyl ester | C21H31NO4 | NNCOZXNZFLUYGG- UHFFFAOYSA-N |
| 61 | Heroin* (heroin) | diacetylmorphine | C21H23NO5 | GVGLGOZIDCSQPN- PVHGPHFFSA-N | |
| 62 | Hydrocodone (hidrokodon) | dihydrocodeinone | C18H21NO3 | LLPOLZWFYMWNKH- CMKMFDCUSA-N | |
| 63 | Hydromorphinol (hidromorfinol) | 14-hydroxydihydromorphine | C17H21NO4 | AABLHGPVOULICI- BRJGLHKUSA-N | |
| 64 | Hydromorphone (hidromorfon) | dihydromorphinone | C17H19NO3 | WVLOADHCBXTIJK- YNHQPCIGSA-N | |
| 65 | Hydroxypethidine (hidroxipetidin) | 4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester | C15H21NO3 | WTJBNMUWRKPFRS- UHFFFAOYSA-N | |
| 66 | Isomethadone (izometadon) | 6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone | C21H27NO | IFKPLJWIEQBPGG- UHFFFAOYSA-N | |
| 67 | Isotonitazene (izotonitazén) | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1Hbenzo[d]imidazol-1-yl]ethan-1-amine | C23H30N4O3 | OIOQREYBGDAYGT- UHFFFAOYSA-N | |
| 68 | Ketobemidone* (ketobemidon) | 4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine | C15H21NO2 | ALFGKMXHOUSVAD- UHFFFAOYSA-N | |
| 69 | Levomethorphan1 (levometorfán) | (-)-3-methoxy-N-methylmorphinan | C18H25NO | MKXZASYAUGDDCJ- CGTJXYLNSA-N | |
| 70 | Levomoramide (levomoramid) | (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine | C25H32N2O2 | INUNXTSAACVKJS- NRFANRHFSA-N | |
| 71 | Levophenacylmorphan (levofenacilmorfán) | (-)-3-hydroxy-N-phenacylmorphinan | C24H27NO2 | RCYBMSQOSGJZLO- BGWNEDDSSA-N | |
| 72 | Levorphanol1 (levorfanol) | (-)-3-hydroxy-N-methylmorphinan | C17H23NO | JAQUASYNZVUNQP- USXIJHARSA-N | |
| 73 | Metazocine (metazocin) | 2’-hydroxy-2,5,9-trimethyl-6,7-benzomorphan | C15H21NO | YGSVZRIZCHZUHB- VRFXOJNMSA-N | |
| 74 | Methadone (metadon) | 6-dimethylamino-4,4-diphenyl-3-heptanone | C21H27NO | USSIQXCVUWKGNF- UHFFFAOYSA-N |
| 75 | Methadone intermediate (metadon intermedier) | 4-cyano-2-dimethylamino-4,4-diphenylbutane | C19H22N2 | GJJQIGFCGLPOQK- UHFFFAOYSA-N | |
| 76 | Methoxyacetylfentanyl (metoxiacetilfentanil) | 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]acetamide | C22H28N2O2 | SADNVKRDSWWFTK- UHFFFAOYSA-N | |
| 77 | Methyldesorphine (metildezorfin) | 6-methyl-∆6-deoxymorphine (derivative of morphine) | C18H21NO2 | CUFWYVOFDYVCPM- GGNLRSJOSA-N | |
| 78 | Methyldihydromorphine (metildihidromorfin) | 6-methyldihydromorphine | C18H23NO3 | NBKVWIJQJMEQLE- NGTWOADLSA-N | |
| 79 | Metonitazene (metonitazén) | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1Hbenzo[d]imidazol-1-yl]ethan-1-amine | C21H26N4O3 | HNGZTLMRQTVPBH- UHFFFAOYSA-N | |
| 80 | Metopon (metopon) | 5-methyldihydromorphinone | C18H21NO3 | NPZXCTIHHUUEEJ- CMKMFDCUSA-N | |
| 81 | Moramide intermediate (moramid intermedier) | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid | C21H25NO3 | AWLNVHVUYACOMZ- UHFFFAOYSA-N | |
| 82 | Morpheridine (morferidin) | 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester | C20H30N2O3 | JDEDMCKQPKGSAX- UHFFFAOYSA-N | |
| 83 | Morphine (morfin) | az ópium és ópium mák fő alkaloidja | C17H19NO3 | BQJCRHHNABKAKU- KBQPJGBKSA-N | |
| 84 | Morphine methobromide (morfin metobromid) | morfin-metobromid és egyéb öt vegyértékű nitrogént tartalmazó morfinszármazékok, beleértve a morfin-N-oxid származékokat, amelyek közé tartozik a kodein-N-oxid is | C18H22BrNO3 | KQUQZJSQMSHWHP- SCLAZZCHSA-N | |
| 85 | Morphine-N-oxide (morfin-N-oxid) | morfinszármazék | C17H19NO4 | AMAPEXTUMXQULJ- APQDOHRLSA-N | |
| 86 | MPPP* | 1-methyl-4-phenyl-4-piperidinol propionate (ester) | C15H21NO2 | BCQMRZRAWHNSBF- UHFFFAOYSA-N | |
| 87 | Myrophine (mirofin) | myristylbenzylmorphine | C38H51NO4 | GODGZZGKTZQSAL- VXFFQEMOSA-N | |
| 88 | Nicomorphine (nikomorfin) | 3,6-dinicotinylmorphine | C29H25N3O5 | HNDXBGYRMHRUFN- CIVUWBIHSA-N | |
| 89 | Noracymethadol (noracimetadol) | (±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane | C22H29NO2 | VWCUGCYZZGRKEE- UHFFFAOYSA-N |
| 90 | Norlevorphanol (norlevorfanol) | (-)-3-hydroxymorphinan | C16H21NO | IYNWSQDZXMGGGI- NUEKZKHPSA-N | |
| 91 | Normethadone (normetadon) | 6-dimethylamino-4,4-diphenyl-3-hexanone | C20H25NO | WCJFBSYALHQBSK- UHFFFAOYSA-N | |
| 92 | Normorphine (normorfin) | demethylmorphine | C16H17NO3 | ONBWJWYUHXVEJS- ZTYRTETDSA-N | |
| 93 | Norpipanone (norpipanon) | 4,4-diphenyl-6-piperidino-3-hexanone | C23H29NO | WCDSHELZWCOTMI- UHFFFAOYSA-N | |
| 94 | Ocfentanyl (okfentanil) | N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin4-yl]acetamide | C22H27FN2O2 | NYISTOZKVCMVEL- UHFFFAOYSA-N | |
| 95 | Opium (ópium) | - | - | ||
| 96 | Oripavine (oripavin) | O3-demethylthebaine vagy 6,7,8,14-tetradehydro-4,5-alphaepoxy-6-methoxy-17-methylmorphinan-3-ol | C18H19NO3 | ZKLXUUYLEHCAMF- UUWFMWQGSA-N | |
| 97 | Orthofluorofentanyl (ortofluorofentanil) | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4yl]propanamide | C22H27FN2O | BKUWDIVZCJNXRA- UHFFFAOYSA-N | |
| 98 | Oxycodone (oxikodon) | 14-hydroxydihydrocodeinone | C18H21NO4 | BRUQQQPBMZOVGD- XFKAJCMBSA-N | |
| 99 | Oxymorphone (oximorfon) | 14-hydroxydihydromorphinone | C17H19NO4 | UQCNKQCJZOAFTQ- ISWURRPUSA-N | |
| 100 | Parafluorobutyrylfentanyl (parafluorobutirilfentanil) | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4yl]butanamide | C23H29FN2O | QZFMCYUBPSLOBP- UHFFFAOYSA-N | |
| 101 | Para-fluorofentanyl* (para-fluorofentanil) | 4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide | C22H27FN2O | KXUBAVLIJFTASZ- UHFFFAOYSA-N | |
| 102 | PEPAP* | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) | C21H25NO2 | BVURVTVDNWSNFN- UHFFFAOYSA-N | |
| 103 | Pethidine (petidin) | 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester | C15H21NO2 | XADCESSVHJOZHK- UHFFFAOYSA-N | |
| 104 | Pethidine intermediate A (petidin A intermedier) | 4-cyano-1-methyl-4-phenylpiperidine | C13H16N2 | ZLFQTZYFXYOGLS- UHFFFAOYSA-N |
| 105 | Pethidine intermediate B (petidin B intermedier) | 4-phenylpiperidine-4-carboxylic acid ethyl ester | C14H19NO2 | QKHMFBKXTNQCTM- UHFFFAOYSA-N | |
| 106 | Pethidine intermediate C (petidin C intermedier) | 1-methyl-4-phenylpiperidine-4-carboxylic acid | C13H17NO2 | KHUPPYUUMRDAAX- UHFFFAOYSA-N | |
| 107 | Phenadoxone (fenadoxon) | 6-morpholino-4,4-diphenyl-3-heptanone | C23H29NO2 | LOXCOAXRHYDLOW- UHFFFAOYSA-N | |
| 108 | Phenampromide (fenampromid) | N-(1-methyl-2-piperidinoethyl)propionanilide | C17H26N2O | DHTRHEVNFFZCNU- UHFFFAOYSA-N | |
| 109 | Phenazocine (fenazocin) | 2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan | C22H27NO | ZQHYKVKNPWDQSL- UHFFFAOYSA-N | |
| 110 | Phenomorphan (fenomorfán) | 3-hydroxy-N-phenethylmorphinan | C24H29NO | CFBQYWXPZVQQTN- QPTUXGOLSA-N | |
| Phenoperidine (fenoperidin) | 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester | C23H29NO3 | IPOPQVVNCFQFRK- UHFFFAOYSA-N | ||
| 112 | Piminodine (piminodin) | 4-phenyl-1-(3-phenylaminopropyl)-piperidine-4-carboxylic acid ethyl ester | C23H30N2O2 | PXXKIYPSXYFATG- UHFFFAOYSA-N | |
| 113 | Piritramide (piritramid) | 1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4carboxylic acid amide | C27H34N4O | IHEHEFLXQFOQJO- UHFFFAOYSA-N | |
| 114 | Proheptazine (proheptazin) | 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane | C17H25NO2 | ZXWAUWBYASJ EOE- UHFFFAOYSA-N | |
| 115 | Properidine (properidin) | 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester | C16H23NO2 | XJKQCILVUHXVIQ- UHFFFAOYSA-N | |
| 116 | Racemethorphan (racemetorfán) | (±)-3-methoxy-N-methylmorphinan | C18H25NO | MKXZASYAUGDDCJ- CGTJXYLNSA-N | |
| 117 | Racemoramide (racemoramid) | (±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]morpholine | C25H32N2O2 | INUNXTSAACVKJS- UHFFFAOYSA-N | |
| 118 | Racemorphan (racemorfán) | (±)-3-hydroxy-N-methylmorphinan | C17H23NO | JAQUASYNZVUNQP- USXIJHARSA-N | |
| 119 | Remifentanil (remifentanil) | 1-(2-methoxy-carbonyl-ethyl)-4-(phenyl-N-propionylamino)piperidine-4-carboxylic acid methyl ester | C20H28N2O5 | ZTVQQQVZCWLTDF- UHFFFAOYSA-N |
| 120 | Sufentanil (szufentanil) | N-[4-(methoxymethyl)-1-[2-(2-thienyl)-ethyl]-4piperidyl]propionanilide | C22H30N2O2S | GGCSSNBKKAUURC- UHFFFAOYSA-N | |
| 121 | Tetrahydrofuranylfentanyl (tetrahidrofuranilfentanil) | THF-F | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran2-carboxamide | C24H30N2O2 | OHJNHKUFSKAANI- UHFFFAOYSA-N |
| 122 | Thebacon (tebakon) | acetyldihydrocodeinone | C20H23NO4 | RRJQTGHQFYTZOW- ILWKUFEGSA-N | |
| 123 | Thebaine (tebain) | ópium alkaloid, a Murvás mákban is megtalálható | C19H21NO3 | FQXXSQDCDRQNQE- VMDGZTHMSA-N | |
| 124 | Thiofentanyl* (tiofentanil) | N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide | C20H26N2OS | YMRFZDHYDKZXPA- UHFFFAOYSA-N | |
| 125 | Tilidine (tilidin) | (±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1carboxylate | C17H23NO2 | WDEFBBTXULIOBB- UHFFFAOYSA-N | |
| 126 | Trimeperidine (trimeperidin) | 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine | C17H25NO2 | UVITTYOJFDLOGI- UHFFFAOYSA-N | |
| 127 | U-47700 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide | C16H22Cl2N2O | JGPNMZWFVRQNGU- UHFFFAOYSA-N | |
| 128 | Valerylfentanyl (valerilfentanil) | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide | C24H32N2O | VCCPXHWAJYWQMR- UHFFFAOYSA-N |
1.2. Ezeken felül a fenti anyagok izomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, amennyiben kémiai szerkezetük alapján léteznek és nem esnek kifejezetten kivételes rendelkezés alá, valamint ezek észterei és éterei, amennyiben ilyen észterek és éterek előfordulnak és nem szerepelnek más jegyzéken, továbbá ezek sói, beleértve a fent említett észterek, éterek, izomerek sóit, amennyiben ilyen sók léteznek.
Jelen K1 jegyzék tartalmilag azonos a New Yorkban, 1961. március 30-án kelt Egységes Kábítószer Egyezmény (a továbbiakban: Kábítószer Egyezmény) aktualizált I. listájával.
1.3. Az 1-gyel jelölt anyagok esetében dextromethorphan (dextrometorfán) [(+)-3-methoxy-N-methylmorphinan] és a dextrorphan (dextrorfán) [(+)-3-hydroxy-N-methylmorphinan] izomerek nem tartoznak nemzetközi ellenőrzés alá.
1.4. A *-gal jelzett anyagok fokozott nemzetközi ellenőrzés alá esnek, és a Kábítószer Egyezmény IV. listáján is szerepelnek.
2. Kábítószerek 2. jegyzéke (K2 jegyzék)
2.1. Kábítószerek az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | Acetyldihydrocodeine (acetildihidrokodein) | kodeinszármazék | C20H25NO4 | LGGDXXJAGWBUSL- BKRJIHRRSA-N | |
| 3 | Codeine (kodein) | 3-methylmorphine | C18H21NO3 | OROGSEYTTFOCAN- DNJOTXNNSA-N | |
| 4 | Dextropropoxyphene (dextropropoxifén) | α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate | C22H29NO2 | XLMALTXPSGQGBX- GCJKJVERSA-N | |
| 5 | Dihydrocodeine (dihidrokodein) | morfinszármazék | C18H23NO3 | RBOXVHNMENFORY- UHFFFAOYSA-N | |
| 6 | Ethylmorphine (etilmorfin) | 3-ethylmorphine | C19H23NO3 | OGDVEMNWJVYAJL- LEPYJNQMSA-N | |
| 7 | Nicocodine (nikokodin) | 6-nicotinylcodeine | C24H24N2O4 | RYBGRHAWFUVMST- MJFIPZRTSA-N | |
| 8 | Nicodicodine (nikodikodin) | 6-nicotinyldihydrocodeine | C24H26N2O4 | GTGRMWCOZHEYRL- MJFIPZRTSA-N | |
| 9 | Norcodeine (norkodein) | N-demethylcodeine | C17H19NO3 | HKOIXWVRNLGFOR- KOFBORESSA-N | |
| 10 | Pholcodine (folkodin) | morpholinylethylmorphine | C23H30N2O4 | GPFAJKDEDBRFOS- FKQDBXSBSA-N | |
| 11 | Propiram (propirám) | N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide | C16H25N3O | ZBAFFZBKCMWUHM- UHFFFAOYSA-N |
2.2. Ezeken felül a fenti anyagok izomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, amennyiben kémiai szerkezetük alapján azok léteznek és nem esnek kifejezetten kivételes rendelkezés alá, továbbá ezek sói, beleértve az izomerjeik sóit, amennyiben ilyen sók létezhetnek.
2.3. A K2 jegyzék tartalmilag azonos a Kábítószer Egyezmény aktualizált II. listájával. Az itt felsorolt hatóanyagok készítményei szerepelhetnek a K3 jegyzéken.
3. Kábítószertartalmú kivételek jegyzéke (K3 jegyzék)
3.1. Az alábbiakban meghatározott kábítószertartalmú készítmények kivételt képeznek jelen rendeletben meghatározott rendelkezések szerint.
3.2. Az alábbi hatóanyagokat tartalmazó egy vagy több komponensű gyógyszerek:
3.2.1. acetyldihydrocodeine (acetildihidrokodein),
3.2.2. codeine (kodein),
3.2.3. dihydrocodeine (dihidrokodein),
3.2.4. ethylmorphine (etilmorfin),
3.2.5. nicocodine (nikokodin),
3.2.6. nicodicodine (nikodikodin),
3.2.7. norcodeine (norkodein),
3.2.8. pholcodine (folkodin),
amennyiben ezen készítmények egy vagy több komponenst tartalmaznak és a kábítószer mennyisége adagegységenként nem haladja meg a 100 mg-ot, és az osztatlan készítményekben (pl. oldat) a kábítószer koncentrációja nem magasabb 2,5 %-nál, kivéve az injekciós készítményeket.
3.3. Az adagolási egységként legfeljebb 100 mg propiram (propiram)-ot tartalmazó és legalább a propirammal azonos mennyiségű metilcellulózt tartalmazó összetett gyógyszerkészítmények.
3.4. Azok az orálisan alkalmazott dextropropoxyphene (dextropropoxifén) tartalmú gyógyszerkészítmények, amelyek dextropropoxifén bázisra számítva adagolási egységenként nem tartalmaznak többet 135 mg-nál, illetve azok az osztatlan gyógyszerkészítmények (pl. oldat), amelyekben a dextropropoxifén bázisra számított koncentrációja nem haladja meg a 2,5%-ot, amennyiben ezen készítmények nem tartalmaznak a pszichotróp anyagokról szóló, Bécsben 1971. év február hó 21. napján aláírt egyezmény (a továbbiakban: Pszichotróp Egyezmény) hatálya alá tartozó egyéb hatóanyagot.
3.5. Azok az összetett cocaine (kokain) gyógyszerkészítmények, amelyek legfeljebb 0,1% kokaint tartalmaznak kokain bázisra számítva és azok az összetett opium (ópium) vagy morphine (morfin) készítmények, amelyek legfeljebb 0,2% morfint tartalmaznak vízmentes morfin bázisra számítva, és amelyek egy vagy több más komponenst oly módon tartalmaznak, hogy a kábítószert ne lehessen könnyen kivitelezhető módszerekkel, vagy olyan mennyiségben visszanyerni, ami közegészségügyi szempontból veszélyt jelentene.
3.6. Azok a difenoxin (difenoxin) tartalmú készítmények, amelyek adagolási egységében a difenoxin mennyisége nem haladja meg a 0,5 mg-ot és legalább a difenoxin 5%-ával egyenlő mennyiségű atropin-szulfátot tartalmaznak.
3.7. Azok a diphenoxylate (difenoxilát) tartalmú gyógyszerkészítmények, amelyek adagolási egységében a bázisra számított difenoxilát mennyisége nem haladja meg a 2,5 mg-ot, és legalább a difenoxilát 1%-ával egyenlő mennyiségű atropin-szulfátot tartalmaznak.
3.8. Az alábbiakkal megegyező összetételű gyógyszerek:
3.8.1. 10 g Pulvis opii
3.8.2. 10 g Ipecacuanhae radix et rhizoma
3.8.3. 80 g Saccharosum (illetve egyéb hatóanyagmentes por vivőanyag).
3.9. A jelen jegyzékben szereplő bármelyik előirattal megegyező gyógyszerek és ezek keverékei bármely olyan anyaggal, amely nem tartalmaz kábítószert."
2. melléklet a 31/2023. (VIII. 22.) BM rendelethez
"2. melléklet a 78/2022. (XII. 28.) BM rendelethez
PSZICHOTRÓP ANYA GOK JEGYZÉKEI
A pszichotróp anyagok e melléklet szerinti jegyzékeiben hivatalos elnevezésként a táblázat A oszlopában a vegyület, anyag nemzetközi neve (International Non-Proprietary Name, a továbbiakban: INN) szerepel. Az angol név vastagon szedve, a magyar név alatta zárójelben található. Amennyiben egy adott vegyületnél vagy anyagnál az International Narcotic Control Board (a továbbiakban: INCB) által közzétett aktuális listán nem áll rendelkezésre INN, hivatalos névként ezen aktuális listán közzétett első egyéb elnevezés kerül átvezetésre. E melléklet táblázatai B oszlopában az INCB által közzétett egyéb elnevezések, esetleges más nevek, rövidítések, illetve a külföldön gyakran használt más írásmód kerülnek feltüntetésre, vesszővel elválasztva. A jegyzékek Coszlopában a kémiai név, illetve dőlt betűvel a leírás, a kémiai névhez tartozó összegképlet a D oszlopban, az InChIKey kémiai azonosító az Eoszlopban szerepel. A jegyzékbe sorolás szempontjából az A-C oszlopban található adatok irányadók, a D és E oszlop adatai a vegyületek számítógépes kereshetőségét biztosítják.
1. Pszichotróp anyagok 1. jegyzéke (P1 jegyzék)
1.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | 1-naphyrone*** (1-nafiron) | 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one | C19H23NO | PDYIKONOBSBEMS- UHFFFAOYSA-N | |
| 3 | 1-PEA*** | 1-amino-1-fenil-etán; 1-fenetil-amin° | C8H11N | RQEUFEKYXDPUSK- UHFFFAOYSA-N | |
| 4 | 25I-NBOMe | 2C-I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2methoxybenzyl)ethanamine | C18H22INO3 | ZFUOLNAKPBFDIJ- UHFFFAOYSA-N |
| 5 | 2-aminoindane*** (2-aminoindán) | 2,3-dihydro-1H-inden-2-amine | C9H11N | LMHHFZAXSANGGM- UHFFFAOYSA-N |
| 6 | 2C-IEU | 2,5-dimethoxy-4-iodophenethylamineEU2 ; 4-Iod-2,5dimethoxyphenethylazan°° | C10H14INO2 | PQHQBRJAAZQXHL- UHFFFAOYSA-N | |
| 7 | 2C-T-2EU | 2,5-dimethoxy-4-ethylthiophenethylamine EU2; 4-Ethylsulfanyl2,5-dimethoxy-phenethylazan°° | C12H19NO2S | HCWQGDLBIKOJPM- UHFFFAOYSA-N | |
| 8 | 2C-T-7EU | 2,5-dimetoxi-4-(n)-propil-tio-fenetil-amin EU2; 2,5-Dimethoxy-4- (propylsulfanyl)-phenethylazan°° | C13H21NO2S | OLEVEPDJOFPJTF- UHFFFAOYSA-N | |
| 9 | 2-DPMP*** (dezoxipipradrol) | Desoxypipradrol | 2-(diphenylmethyl)piperidine | C18H21N | RWTNXJXZVGHMGI- UHFFFAOYSA-N |
| 10 | 2-naphyrone*** (2-nafiron) | 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one | C19H23NO | DTNUPBSOODGRKW- UHFFFAOYSA-N | |
| 11 | 3,4-dichloromethylphenidate *** | 3,4-CTMP | methyl-2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate | C14H17Cl2NO2 | JU KM AYKVHWKRKY- UHFFFAOYSA-N |
| 12 | 3,4-methylenedioxypyrovalerone ** (3,4-metiléndioxipirovaleron) | MDPV | (RS)-1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1one | C16H21NO3 | SYHGEUNFJIGTRX- UHFFFAOYSA-N |
| 13 | 3F-phenmetrazine*** | meta-fluoro-phenmetrazine, meta-F-phenmetrazine | 2-(3-fluorophenyl)-3-methylmorpholine | C11H14FNO | VHYVKJAQSJCYCK- UHFFFAOYSA-N |
| 14 | 3-MeO-PCE*** | N-ethyl-1-(3-methoxyphenyl)cyclohexanamine | C15H23NO | OFGOOZLOGUNDFS- UHFFFAOYSA-N |
| 15 | 3-MeO-PCP** | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | C18H27NO | BQQSZHHKGPOXLN- UHFFFAOYSA-N |
| 16 | 4-MAEU (4-metilamfetamin) | 4-methylamphetamine | 1-(4-methylphenyl)propan-2-amine | C10H15N | ZDHZDWSHLNBTEB- UHFFFAOYSA-N |
| 17 | 4-benzylpiperidine*** | 4-(phenylmethyl)piperidine | C12H17N | ABGXADJ DTPFFSZ- UHFFFAOYSA-N | |
| 18 | 4F-MDMB-BICA EU | methyl 2-([1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino)-3,3dimethylbutanoate | C20H27FN2O3 | QIKHYQCWGUGFBB- UHFFFAOYSA-N | |
| 19 | 4-MEC** | 4-methylethcathinone | 2-(ethylamino)-1-(4-methylphenyl)propan-1-one | C12H17NO | ZOXZWYWOECCBSH- UHFFFAOYSA-N |
| 20 | 4-MeO-PCP*** | 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine | C18H27NO | MUZGGFNYVLGUFS- UHFFFAOYSA-N | |
| 21 | 4-methylaminorex (4-metilaminorex) | (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline | C10H12N2O | UQBMYDFWFGESC- CBAPKCEASA-N | |
| 22 | 4-MTA | α-methyl-4-methylthiophenethylamine | C10H15NS | OLEWMKVPSUCNLG- UHFFFAOYSA-N | |
| 23 | 5F-AB-PINACA*** | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1Hindazole-3-carboxamide | C18H25FN4O2 | WCBYXIBEPFZUBG- UHFFFAOYSA-N | |
| 24 | 5-IAI*** | 5-iodo-2,3-dihydro-1H-inden-2-amine | C9H10IN | BIHPYCDDPGNWQO- UHFFFAOYSA-N | |
| 25 | 5-IT EU | 5-(2-aminopropyl)indole | C11H14N2 | AULGMISRJWGTBA- UHFFFAOYSA-N |
| 26 | 5-MeO-AMT*** | 1-(5-methoxy-1H-indol-3-yl)propan-2-amine | C12H16N2O | OGNJZVNNKBZFRM- UHFFFAOYSA-N | |
| 27 | A-836,339*** | N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]2,2,3,3-tetramethylcyclopropane-carboxamide | C16H26N2O2S | JKGIMVBQKSRTGX- UHFFFAOYSA-N | |
| 28 | AH-7921 EU | 3,4-dichloro-N-([1- (dimethylamino)cyclohexyl]methyl)benzamide | C16H22Cl2N2O | JMZROFPPEXCTST- UHFFFAOYSA-N | |
| 29 | AL*** | 4-allil-oxi-3,5-dimetoxi-fenetil-amin ° | C13H19NO3 | JNUAYHHGCXYBHX- UHFFFAOYSA-N | |
| 30 | alpha-PBT*** (alfa-PBT) | a-PBT, α- Pyrrolidinobutiothiophenone | 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one | C12H17NOS | NGVNNJYFJYTCCO- UHFFFAOYSA-N |
| 31 | alpha-PVP** | α-pyrrolidinovalerophenone | 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | C15H21NO | YDIIDRWHPFMLGR- UHFFAOYSA-N |
| 32 | alpha-PVT*** | α-PVT, alpha- pyrrolidinopentiothiophenone | 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one | C13H19NOS | OOSRPGUQJAKBLV- UHFFFAOYSA-N |
| 33 | AM-1248 azepane isomer *** | adamant-1-yl[1-(1-methylazepan-3-yl)-1H-indol-3-yl] methanone | C26H34N2O | HSCSEKGAOWTVDH- UHFFFAOYSA-N | |
| 34 | AM-2201** | JWH-2201 | 1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1yl)methanone | C24H22FNO | ALQFAGFPQCBPED- UHFFFAOYSA-N |
| 35 | AMT*** (alfa-metiltriptamin) | 1-(1H-indol-3-yl)propan-2-amine | C11H14N2 | QSQQQURBVYWZKJ- UHFFFAOYSA-N |
| 36 | BDB*** | 1-(1,3-benzo-dioxol-5-il)-2-bután-amin°; 1-(1,3-benzodioxol-5yl)butan-2-ylazan°° | C11H15NO2 | VHMRXGAIDDCGDU- UHFFFAOYSA-N | |
| 37 | Brolamfetamine (brolamfetamin) | DOB | (±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine | C11H16BrNO2 | FXMWUTGUCAKGQL- UHFFFAOYSA-N |
| 38 | BZPEU3 | N-Benzylpiperazine | 1-benzilpiperazinEU3; 1-benzil-1,4-diaza-ciklohexán; N-benzilpiperazin | C11H16N2 | IQXXEPZFOOTTBA- UHFFFAOYSA-N |
| 39 | β-Me-PEA*** | 2-phenylpropan-1-amine | C9H13N | AXORVIZLPOGIRG- UHFFFAOYSA-N | |
| 40 | Camfetamine*** (kamfetamin) | N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine | C14H19N | CTVMYAZECFXZLN- UHFFFAOYSA-N | |
| 41 | Cathinone (katinon) | (-)-(S)-2-amino-propiophenone | C9H11NO | PUAQLLVFLMYYJJ- ZETCQYMHSA-N | |
| 42 | CP 47,497 C8-homológ*** | 2-(3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol | C22H36O2 | HNMJDLVMIUDJNH- UHFFFAOYSA-N | |
| 43 | CRA 13*** | naphthalen-1-yl [4-(pentyloxy)naphthalen-1-yl]methanone | C26H24O2 | RSUMDJRTAFBISX- UHFFFAOYSA-N | |
| 44 | D2PM*** (difenilprolinol) | Diphenylprolinol | diphenyl(pyrrolidin-2-yl)methanol | C17H19NO | OGCGXUGBDJGFFY- UHFFFAOYSA-N |
| 45 | DBZP*** | 1,4-dibenzylpiperazine | C18H22N2 | YPUGLZQRXQQCSX- UHFFFAOYSA-N | |
| 46 | Desoxy-D2PM*** (dezoxi-D2PM) | 2-(diphenylmethyl)pyrrolidine | C17H19N | OXOBKZZXZVFOBB- UHFFFAOYSA-N | |
| 47 | DET | 3-[2-(diethyl-amino)ethyl]indole | C14H20N2 | LSSUMOWDTKZHHT- UHFFFAOYSA-N | |
| 48 | Dimethocaine*** (dimetokain) | 3-(diethylamino)-2,2-dimethylpropyl-4-aminobenzoate | C16H26N2O2 | OWQIUQKMMPDHQQ- UHFFFAOYSA-N |
| 49 | Diphenidine** | 1,2-diphenylethylpiperidine, DPD, 1,2-DEP, DIPH | 1-(1,2-diphenylethyl)piperidine | C19H23N | JQWJJJYHVHNXJH- UHFFFAOYSA-N |
| 50 | DMA | (±)-2,5-dimethoxy-α-methylphenethylamine | C11H17NO2 | LATVFYDIBMDBSY- UHFFFAOYSA-N | |
| 51 | DMAA*** | 4-methylhexan-2-amine | C7H17N | YAHRDLICUYEDAU- UHFFFAOYSA-N | |
| 52 | DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6Hdibenzo[b,d]pyran-1-ol | C25H38O2 | QBEFIFWEOSUTKV- UHFFFAOYSA-N | |
| 53 | DMT | 3-[2-(dimethylamino)ethyl]indole | C12H16N2 | DMULVCHRPCFFGV- UHFFFAOYSA-N | |
| 54 | DOC | 4-chloro-2,5-dimethoxyamfetamine; 2,5-dimetoxi-4-klóramfetamin° | C11H16ClNO2 | ACRITBNCBMTINK- UHFFFAOYSA-N | |
| 55 | DOET | (±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine | C13H21NO2 | HXJKWPGVENNMCC- UHFFFAOYSA-N | |
| 56 | EG-018*** | (naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)-methanone | C28H25NO | FJMMDJDPNLZYLA- UHFFFAOYSA-N | |
| 57 | Etaqualone*** (etakvalon) | 3-(2-ethylphenyl)-2-methylquinazolin-4(3H)-one | C17H16N2O | UVTJKLLUVOTSOB- UHFFFAOYSA-N | |
| 58 | Eticyclidine (eticiklidin) | PCE | N-ethyl-1-phenylcyclohexylamine | C14H21N | IFYLVUHLOOCYBG- UHFFFAOYSA-N |
| 59 | Etryptamine (etriptamin) | 3-(2-aminobutyl)indole | C12H16N2 | ZXUMUPVQYAFTLF- UHFFFAOYSA-N | |
| 60 | FLEA*** | N-hidroxi-N-metil-3,4-metilén-dioxi-amfetamin; N-hidroxi-3,4-metilén-dioxi-metamfetamin°; N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]-N-methylhydroxylamin°° | C11H15NO3 | ORADFQZOLNHWRQ- UHFFFAOYSA-N |
| 61 | GBL*** (gamma-butirolakton) | gamma-butyrolactone | dihydrofuran-2(3H)-one | C4H6O2 | YEJRWHAVMIAJKC- UHFFFAOYSA-N |
| 62 | Homoamphetamine*** | 3-amino-1-phenyl-butane | C10H15N | WECUIGDEWBNQJJ- UHFFFAOYSA-N | |
| 63 | HU-210*** | 9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | C25H38O3 | SSQJFGMEZBFMNV- UHFFFAOYSA-N | |
| 64 | Ibogain*** | (6R,6aS,7S,9R)-7-ethyl-2-methoxy-6,6a,7,8,9,10,12,13octahydro-5H-6,9-methanopyrido[10,20:1,2]azepino[4,5b]indole | C20H26N2O | HSIBGVUMFOSJPD- CFDPKNGZSA-N | |
| 65 | JWH-018** | AM-678 | naphthalen-1-yl (1-pentyl-1H-indol-3-yl)methanone | C24H23NO | JDNLPKCAXICM BW- II HFFFAOYSA-N |
| 66 | JWH-073*** | (1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | C23H21NO | VCHHHSMPMLNVGS- U HFFFAOYSA-N | |
| 67 | JWH-081*** | (4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3yl)methanone | C25H25NO2 | UBMPKJKGUQDHRM- U HFFFAOYSA-N | |
| 68 | JWH-122*** | (4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | C25H25NO | HUKJQMKQFWYIHS- U HFFFAOYSA-N | |
| 69 | JWH-210*** | (4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | C26H27NO | LACIUQLUNACUKC- U HFFFAOYSA-N | |
| 70 | (+)-Lysergide ( (+)-lizergid ) | LSD, LSD-25 | 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide | C20H25N3O | VAYOSLLFUXYJDT- RDTXWAMCSA-N |
| 71 | MAL*** | 3,5-dimetoxi-4-metallil-oxi-fenetil-amin°; 3,5-dimethoxy-4-(2-methylallyloxy)-phenethylazan°° | C14H21NO3 | FOXJFBFFGULACD- U HFFFAOYSA-N | |
| 72 | MBDB*** | 2-(metil-amino)-1-(3,4-metilén-dioxi-fenil)-bután vagy N-metil-1- (1,3-benzo-dioxol-5-il)-2-bután-amin°; [1-(1,3-Benzodioxol-5-yl)butan-2-yl](methyl)azan°° | C12H17NO2 | USWVWJSAJAEEHQ- U HFFFAOYSA-N | |
| 73 | MBZP*** | 1-benzyl-4-methylpiperazine | C12H18N2 | MUOKPBESJWYGL- U HFFFAOYSA-N |
| 74 | mCPP*** (meta-klorofenilpiperazin) | meta-chlorophenylpiperazine°; [1-(3-chlorophenyl)piperazine]°° | C10H13ClN2 | VHFVKMTVMIZMIK- UHFFFAOYSA-N | |
| 75 | MDAI*** | 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine | C10H11NO2 | FQDRMHHCWZAXJM- UHFFFAOYSA-N | |
| 76 | MDE (N-etil-MDA) | N-ethyl MDA, MDEA | (±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine | C12H17NO2 | PVXVWWANJIWJOO- UHFFFAOYSA-N |
| 77 | MDMA | (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine | C11H15NO2 | SHXWCVYOXRDMCX- UHFFFAOYSA-N | |
| 78 | MDMB-CHMICA** | Methyl 2-([1-(cyclohexylmethyl)indole-3-carbonyl]amino)-3,3dimethylbutanoate | C23H32N2O3 | SRJKCVHWIDFUBO- UHFFFAOYSA-N | |
| 79 | MephedroneEU (mefedron) | 4-methylmethcathinone, 4methylephedrone, 4-MMC | (RS)-2-methylamino-1-(4-methylphenyl)propan1-one | C11H15NO | YELGFTGWJGBAQU- UHFFFAOYSA-N |
| 80 | Mescaline (meszkalin) | 3,4,5-trimethoxyphenethylamine | C11H17NO3 | RHCSKNNOAZULRK- UHFFFAOYSA-N | |
| 81 | Methcathinone (metkatinon) | 2-(methylamino)-1-phenylpropan-1-one | C10H13NO | LPLLVINFLBSFRP- UHFFFAOYSA-N | |
| 82 | Methoxetamine** (metoxetamin) | MXE | (RS)-2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone | C15H21NO2 | LPKTWLVEGBNOOX- UHFFFAOYSA-N |
| 83 | Methylone** (Metilon) | beta-keto-MDMA | (RS)-2-methylamino-1-(3,4- methylenedioxyphenyl)propan-1-one | C11H13NO3 | VKEQBMCRQDSRET- UHFFFAOYSA-N |
| 84 | Methiopropamine** (metiltienil-propamin) | MPA, Methylthietnylpropamine | 1-(thiophen-2-yl)-2-methylaminopropane | C8H13NS | HPHUWHKFQXTZPS- UHFFFAOYSA-N |
| 85 | MMDA | 5-methoxy-α-methyl-3,4-(methylenedioxy)phenylethylamine | C11H15NO3 | YQYUWUKDEVZFDB- UHFFFAOYSA-N | |
| 86 | MT-45EU | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine | C24H32N2 | IGBRRSIHEGCUEN- UHFFFAOYSA-N |
| 87 | MTP*** | methcathinone thiophen analog | 2-(methylamino)-1-(thiophen-2-yl)propan-1-one | C8H11NOS | DOZQPYDMJMLVKX- UHFFFAOYSA-N |
| 88 | MTTA*** | MTA, Mephtetramine | 2-[(methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one | C12H15NO | FTRWLSZFQILOOD- UHFFFAOYSA-N |
| 89 | MXP*** | methoxyphenidine, 2-MeOdiphenidine | 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine | C20H25NO | QXXCUXIRBHSITD- UHFFFAOYSA-N |
| 90 | N-(2-methoxyethyl)-N-(1- methylethyl)-2-(1-pentyl-1H-indol-3yl)-4-thiazol-methanamine*** | N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3yl)-4-thiazol-methanamine | C23H33N3OS | PSAKYYVEWAWJL- UHFFFAOYSA-N | |
| 91 | N,N-diethyl-2-(1-pentyl-1H-indol-3yl)-4-thiazol- methanamine*** | N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine | C21H29N3S | PCNLLVFKBKMRDB- UHFFFAOYSA-N | |
| 92 | N-ethylnorketamine*** | 2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone | C14H18ClNO | ITBBBZIIFJJMDU- UHFFFAOYSA-N | |
| 93 | N-hydroxy MDA (N-hidroxi-MDA) | (±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl] hydroxylamine | C10H13NO3 | FNDCTJYFKOQGTL- UHFFFAOYSA-N | |
| 94 | Nitracaine*** | 3-(diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate | C16H24N2O4 | SPTIETJWCCCJSE- UHFFFAOYSA-N | |
| 95 | N-Me-1-PEA*** | 1-(N-metil-amino)-1-fenil-etán; N-metil-1-fenetil-amin | C9H13N | RCSSHZGQHHEHPZ- UHFFFAOYSA-N | |
| 96 | ODT*** (O-dezmetiltramadol) | O-desmethyltramadol | 3-(2-[(dimethylamino)methyl]-1-hydroxycyclohexyl)phenol | C15H23NO2 | UWJUQVWARXYRCG- UHFFFAOYSA-N |
| 97 | Parahexyl (parahexil) | 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6Hdibenzo[b,d]pyran-1-ol | C22H32O2 | OORFXDSWECAQLI- UHFFFAOYSA-N |
| 98 | para-Methyl-4-methylaminorex ** | 4,4’-DMAR | 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine | C11H14N2O | NPILLHMQNMXXTL- UHFFFAOYSA-N |
| 99 | Pentedron** | β-ethyl-methcathinone (β-etilmetkatinon), pentedrone | (±)-2-(methylamino)-1-phenylpentan-1-one | C12H17NO | WLIWIUNEJRETFX- UHFFFAOYSA-N |
| 100 | pFBT*** (fluortropakokain) | 4-fluorotropacocaine | 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoate | C15H18FNO2 | YXDFSLSXLYAAPF- UHFFFAOYSA-N |
| 101 | pFPP*** | 1-(4-fluorophenyl)piperazine | C10H13FN2 | AVJKDKWRVSSJPK- UHFFFAOYSA-N | |
| 102 | Phenazepam** (fenazepam) | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4benzodiazepin-2-one | C15H10BrClN2O | CGMJQQJSWIRRRL- UHFFFAOYSA-N | |
| 103 | PMA | 1-(4-methoxyphenyl)propan-2-amine | C10H15NO | NEGYEDYHPHMHGK- UHFFFAOYSA-N | |
| 104 | PMMAEU (parametoxi-metilamfetamin) | para- methoxymethylamphetamine | paramethoxymethylamphetamineEU1; N-methyl-1-(4-methoxyphenyl)-2-aminopropane vagy pmethoxy-N,α-dimethylphenethylamine vagy 1-(4methoxyphenyl)-N-methylpropan-2-amine | C11H17NO | UGFMBZYKVQSQFX- UHFFFAOYSA-N |
| 105 | Psilocine (pszilocin) | Psilotsin | 3-[2-(dimethylamino)ethyl]indol-4-ol | C12H16N2O | SPCIYGNTAMCTRO- UHFFFAOYSA-N |
| 106 | Psilocybine (pszilocibin) | 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate | C12H17N2O4P | QVDSEJDULKLHCG- UHFFFAOYSA-N | |
| 107 | Rolicyclidine (roliciklidin) | PHP, PCPY | 1-(1-phenylcyclohexyl)pyrrolidine | C16H23N | FYOWWXMGDATDQY- UHFFFAOYSA-N |
| 108 | Salvinorin A*** (Szalvinorin A) | (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2Hnaphtho[2,1-c]pyran-7-carboxylic acid methyl ester | C23H28O8 | OBSYBRPAKCASQB- AGQYDFLVSA-N | |
| 109 | STP | DOM | 2,5-dimethoxy-α,4-dimethylphenethylamine | C12H19NO2 | NTJQREUGJKIARY- UHFFFAOYSA-N |
| 110 | Tenamfetamine (tenamfetamin) | MDA | α-methyl-3,4-(methylenedioxy)phenethylamine | C10H13NO2 | NGBBVGZWCFBOGO- UHFFFAOYSA-N |
| Tenocyclidine (tenociklidin) | TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine | C15H23NS | JUZZEWSCNBCFRL- UHFFFAOYSA-N | |
| 112 | Tetrahydrocannabinol, the following isomers and their stereochemical variants (a következő tetrahidro-kannabinol izomerek és szterokémiai variánsaik) [THC] | delta-6a(10a)-THC | 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol | C21H30O2 | NEBZNJDFIPBXCS- UHFFFAOYSA-N |
| delta-6a(7)-THC | 8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | C21H30O2 | UQOUHXDCXBITSF- UHFFFAOYSA-N | ||
| delta-7-THC | 6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol | C21H30O2 | WWYMYGIVLCKTBL- UHFFFAOYSA-N | ||
| delta-8-THC | 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | C21H30O2 | HCAWPGARWVBULJ- UHFFFAOYSA-N | ||
| delta-10-THC | 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol | C21H30O2 | YLTWYAXW DLZZCU- UHFFFAOYSA-N | ||
| delta-9(11)-THC | 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3pentyl-6H-dibenzo[b,d]pyran-1-ol | C21H30O2 | AOYYFUGUUIRBML- UHFFFAOYSA-N | ||
| 113 | TFMPP*** | 1-[3-(trifluoromethyl)phenyl]piperazine | C11H13F3N2 | KKIMDKMETPPURN- UHFFFAOYSA-N | |
| 114 | TMA (trimetoxiamfetamin) | (±)-3,4,5-trimethoxy-α-methylphenethylamine | C12H19NO3 | WGTASENVNYJZBK- UHFFFAOYSA-N | |
| 115 | TMA-2EU (2,4,5- trimetoxiamfetamin) | 2,4,5-trimethoxyamphetamineEU2; 1-(2,4,5-trimethoxyphenyl)propan-2-ylazan°° | C12H19NO3 | TVSIMAWGATVNGK- UHFFFAOYSA-N | |
| 116 | 3-methylmethcathinone, 3-MMC | 2-(methylamino)-1-(3-methylphenyl)propan-1-one | C11H15NO | QDNXSIYWHYGMCD- UHFFFAOYSA-N | |
| 117 | 3-chloromethcathinone, 3-CMC | 1-(3-chlorophenyl)-2-(methylamino)propan-1-one | C10H12ClNO | VOEFELLSAAJCHJ- UHFFFAOYSA-N |
1.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek, és nem esnek kifejezetten kivételes rendelkezés alá, továbbá ezek sói, beleértve sztereoizomerjeik sóit, amennyiben ilyen sók léteznek.
1.3. A P1 jegyzéken az alábbi anyagok kerülnek feltüntetésre:
1.3.1. A Pszichotróp Egyezmény aktualizált I. Listáján szereplő anyagok,
1.3.2. EU jelöléssel a tiltott kábítószer-kereskedelem területén a bűncselekmények tényállási elemeire és a büntetésekre vonatkozó minimumszabályok megállapításáról szóló, 2004. Október 25-i 2004/757/IB tanácsi kerethatározatban szereplő anyagok,
1.3.3. ** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb, mint a Pszichotróp Egyezmény előírása,
1.3.4. *** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb és nem szerepelnek a Kábítószer Egyezmény és Pszichotróp Egyezmény jegyzékeiben.
1.4. Jelen jegyzék C oszlopában ° jellel és dőlt betűvel szedve kerülnek jelölésre a korábbi magyar hivatalos nevek, míg °° jellel és dőlt betűvel szedve a német BtMG (Betäubungsmittelgesetz 22. Dezember 2003) által alkalmazott IUPAC megnevezés, ha ezek rendelkezésre állnak.
2. Pszichotróp anyagok 2. Jegyzéke (P2 jegyzék)
2.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | 2C-B | 4-bromo-2,5-dimethoxyphenethylamine | C10H14BrNO2 | YMHOBZXQZVXHBM- UHFFFAOYSA-N | |
| 3 | 4-CMC | 4-chloromethcathinone, clephedrone | 1-(4-chlorophenyl)-2-(methylamino)-1-propanone | C10H12GNO | UEJBEYOXRNGPEI- UHFFFAOYSA-N |
| 4 | 4-FA | 4-fluoroamphetamine | 1-(4-fluorophenyl)propan-2-amine | C9H12FN | DGXWNDGLEOIEGT- UHFFFAOYSA-N |
| 5 | 4F-MDMB-BINACA | Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate | C19H26FN3O3 | GZGKSDAMWRWYOZ- UHFFFAOYSA-N | |
| 6 | 5F-AKB-48 | 5F-APINACA | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3carboxamide | C23H30FN3O | UCMFSGVIEPXYIV- UHFFFAOYSA-N |
| 7 | 5F-AMB | 5F-AMB-PINACA, 5F-MMB-PINACA | Methyl 2-(([1-(5-fluoropentyl)-1H-indazol-3yl]carbonyl)amino)-3-methylbutanoate | C19H26FN3O3 | SAFXSUZMRLTBMM- UHFFFAOYSA-N |
| 8 | 5F-MDMB-PICA | 5F-MDMB-2201 | Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate | C21H29FN2O3 | CHSUEEBESACQDV- UHFFFAOYSA-N |
| 9 | 5F-ADB | 5F-MDMB-PINACA | Methyl 2-([1-(fluoropentyl)-1H-indazole-3-carbonyl]amino)3,3-dimethylbutanoate | C20H28FN3O3 | PWEKNGSNNAKWBL- UHFFFAOYSA-N |
| 10 | 5F-PB-22 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | C23H21FN2O2 | MBOCMBFDYVSGU- UHFFFAOYSA-N | |
| 11 | AB-CHMINACA | N-[1-amino-3-methyl-1-oxobutan-2-yl]-1(cyclohexylmethyl)-1H-indazole-3-carboxamide | C20H28N4O2 | KJNZIEGLNLCWTQ- UHFFFAOYSA-N | |
| 12 | AB-FUBINACA | N-[1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4fluorophenyl)methyl]indazole-3-carboxamide | C20H21FN4O2 | AKOOIMKXADOPDA- UHFFFAOYSA-N | |
| 13 | AB-PINACA | N-[1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1Hindazole-3-carboxamide | C18H26N4O2 | GIMHPAQOAAZSHS- UHFFFAOYSA-N | |
| 14 | ADB-CHMINACA | MAB-CHMINACA | N-[1-amino-3,3-dimethyl-1-oxobutan-2- yl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide | C21H30N4O2 | ZWCCSIUBHCZKOY- UHFFFAOYSA-N |
| 15 | ADB-FUBINACA | N-[1-amino-3,3-dimethyl-1-oxobutan-2- yl]-1-[(4fluorophenyl)methyl]-1H-indazole-3-carboxamide | C21H23FN4O2 | ZSSGCSINPVBLQD- UHFFFAOYSA-N | |
| 16 | alpha-PHP | (RS)-1-phenyl-2-(pyrrolidine-1-yl)hexan-1-one | C16H23NO | KYIJLDDXQWBNGX- UHFFFAOYSA-N | |
| 17 | Amfetamine (amfetamin) | amphetamine | (±)-α-methylphenethylamine | C9H13N | KWTSXDURSIMDCE- UHFFFAOYSA-N |
| 18 | Amineptine (amineptin) | 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5yl)amino]heptanoic acid | C22H27NO2 | ONNOFKFOZAJDHT- UHFFFAOYSA-N | |
| 19 | Buprenorphine** (buprenorfin) | 21-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]6,14-endo-ethano-6,7,8,14-tetrahydrooripavine | C29H41NO4 | RMRJXGBAOAMLHD- IHFGGWKQSA-N | |
| 20 | CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3carboxamide | C22H24N4O | JGTSOWOPISVAHG-UHFFFAOYSA-N | |
| 21 | CUMYL-PEGACLONE | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3b]indol-1-one | C25H28N2O | AWHWTKXMUJLSRM- UHFFFAOYSA-N | |
| 22 | Dexamfetamine (dexamfetamin) | dexamphetamine | (+)-α-methylphenethylamine | C9H13N | KWTSXDURSIMDCE- QMMMGPOBSA-N |
| 23 | Dronabinol2 (delta-9-tetrahidrokannabinol [delta-9-THC] és sztereokémiai varánsai) | delta-9-tetrahydrocannabinol and its stereochemical variants | (6aR, 10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl- 6H-dibenzo[b,d]pyran-1-ol | C21H30O2 | CYQFCXCEBYINGO- IAGOWNOFSA-N |
| 24 | Ethylone (etilon) | (RS)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1- one | C12H15NO3 | MJ EM IOXXNCZZFK-U H FFFAOYSA-N | |
| 25 | Ethylphenidate (etilfenidát) | ”Nopaine”, ”Fake cocaine” | Ethyl 2-phenyl-2-(piperidin-2-yl)acetate | C15H21NO2 | AIVSIRYZIBXTMM-UHFFFAOYSA-N |
| 26 | Eutylone (eutilon) | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one | C13H17NO3 | YERSNXHEOIYEGX-UHFFFAOYSA-N | |
| 27 | Fenetylline (fenetillin) | 7-(2-[(α-methylphenethyl)amino]ethyl)theophylline | C18H23N5O2 | NMCHYWGKBADVMK- UH FFFAOYSA-N | |
| 28 | FUB-AMB | MMB-FUBINACA, AMBFUBINACA | Methyl 2-((1-[(4-fluorophenyl)methyl]-1H-indazole-3carbonyl)amino)-3-methylbutanoate | C21H22FN3O3 | FRFFLYJQPCIIQB-UHFFFAOYSA-N |
| 29 | gamma-Hydroxybutiric acid (gamma-hidroxi-vajsav) | GHB | γ-hydroxybutyric acid | C4H8O3 | SJZRECIVHVDYJC- UHFFFAOYSA-N |
| 30 | Ketamine*** (ketamin) | 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone | C13H16ClNO | YQEZLKZALYSWHR- UHFFFAOYSA-N | |
| 31 | Levamfetamine (levamfetamin) | levamphetamine | (-)-(R)-α-methylphenethylamine | C9H13N | KWTSXDURSIMDCE- MRVPVSSYSA-N |
| 32 | Levomethamphetamine (levometamfetamin) | levomethamphetamine | (-)-N,α-dimethylphenethylamine | C10H15N | MYWUZJCMWCOHBA- SECBINFHSA-N |
| 33 | MDMB-4en-PINACA | Methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate | C20H27N3O3 | LWOCBHBFWNGPGM- UHFFFAOYSA-N | |
| 34 | Mecloqualone (meklokvalon) | 3-(o-chlorophenyl)-2-methyl-4-(3H)-quinazolinone | C15H11ClN2O | SFITWQDBYUMAPS- UHFFFAOYSA-N | |
| 35 | Metamfetamine (metamfetamin) | metamphetamine | (+)-(S)-N,α-dimethylphenethylamine | C10H15N | MYWUZJCMWCOHBA- VIFPVBQESA-N |
| 36 | Metamfetamine racemate (metamfetamin racemát) | metamphetamine racemate | (±)-N,α-dimethylphenethylamine | C10H15N | MYWUZJCMWCOHBA- UHFFFAOYSA-N |
| 37 | Methaqualone (metakvalon) | 2-methyl-3-o-tolyl-4-(3H)-quinazolinone | C16H14N2O | JEYCTXH KTXCGPB-UHFFFAOYSA-N | |
| 38 | Methylphenidate (metilfenidát) | Methylα-phenyl-2-piperidine acetate | C14H19NO2 | DUGOZIWVEXMGBE- UHFFFAOYSA-N | |
| 39 | N-ethylhexed rone | 2-(ethylamino)-1-phenyl-1-hexanone | C14H21NO | CWNKMHIETKEBCA- UHFFFAOYSA-N | |
| 40 | N-ethyl norpentylone | ephylone | 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one | C14H19NO3 | VERDHJIMZYXGIW-UHFFFAOYSA-N |
| 41 | Pentazocine** (pentazocin) | (2R,*6R,*11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol | C19H27NO | VOKSWYLNZZRQPF- GDIGMMSISA-N | |
| 42 | Phencyclidine (fenciklidin) | PCP | 1-(1-phenylcyclohexyl)piperidine | C17H25N | JTJMJGYZQZDUJJ- UHFFFAOYSA-N |
| 43 | Phenmetrazine (fenmetrazin) | 3-methyl-2-phenylmorpholine | C11H15NO | OOBHFESNSZDWIU- UHFFFAOYSA-N | |
| 44 | Poppy straw** (mákszalma) | - | - | ||
| 45 | Secobarbital (szekobarbitál) | 5-allyl-5-(1-methylbutyl)barbituric acid | C12H18N2O3 | KQPKPCNLIDLUMF- UHFFFAOYSA-N | |
| 46 | Tapentadol*** (tapentadol) | 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]- phenol | C14H23NO | KWTWDQCKEHXFFR- SMDDNHRTSA-N | |
| 47 | UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3tetramethylcyclopropyl)methanone | C21H29NO | NBMMIBNZVQFQEO- UHFFFAOYSA-N | |
| 48 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3tetramethylcyclopropyl)methanone | C21H28FNO | PXLDPUUMIHVLEC- UHFFFAOYSA-N | |
| 49 | Zipeprol (zipeprol) | α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-1piperazineethanol | C23H32N2O3 | VSTN NAYSCJQCQI- UHFFFAOYSA-N |
2.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek, és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, amennyiben ilyen sók léteznek.
2.3. A P2 jegyzéken az alábbi anyagok kerülnek feltüntetésre:
2.3.1. A Pszichotróp Egyezmény aktualizált II. listáján szereplő anyagok,
2.3.2. ** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb, mint a Pszichotróp Egyezmény előírása,
2.3.3.*** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb és nem szerepelnek a Kábítószer Egyezmény és Pszichotróp egyezmény jegyzékeiben.
2.4. A 2 jellel jelölt anyag esetében a dronabinol megjelölés csak a (-)-trans-delta-9-tetrahydrocannabinol sztereoizomerre vonatkozik.
3. Pszichotróp anyagok 3. jegyzéke (P3 jegyzék)
3.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | Amobarbital (amobarbitál) | 5-ethyl-5-isopentylbarbituric acid | C11H18N2O3 | VIROVYVQCGLO- UHFFFAOYSA-N | |
| 3 | Butalbital (butalbitál) | 5-allyl-5-isobutylbarbituric acid | C11H16N2O3 | UZVHFVZFNXBMQJ- UHFFFAOYSA-N | |
| 4 | Cathine (katin) | (+)-norpseudoephedrine | (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol | C9H13NO | DLNKOYKMWOXYQA- IONNQARKSA-N |
| 5 | Cyclobarbital (ciklobarbitál) | 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid | C12H16N2O3 | WTYGAUXICFETTC- UHFFFAOYSA-N | |
| 6 | Flunitrazepam (flunitrazepám) | 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4benzodiazepin-2-one | C16H12FN3O3 | PPTYJ KAXVCC BDU- UHFFFAOYSA-N | |
| 7 | Glutethimide (glutetimid) | 2-ethyl-2-phenylglutarimide | C13H15NO2 | JMBQKKAJIKAWKF- UHFFFAOYSA-N | |
| 8 | Pentobarbital (pentobarbitál) | 5-ethyl-5-(1-methylbutyl)barbituric acid | C11H18N2O3 | WEXRUCMBJFQVBZ- UHFFFAOYSA-N |
3.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek, és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, amennyiben ilyen sók léteznek.
3.3. Jelen P3 jegyzék a Pszichotróp Egyezmény aktualizált III. listája alapján készült.
4. Pszichotróp anyagok 4. jegyzéke (P4 jegyzék)
4.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
| A | B | C | D | E | |
| 1 | Hivatalos név (magyar név) | Más név vagy rövidítés, külföldön gyakran használt írásmód | Kémiai név / Leírás | Összegképlet | InChIKey kémiai azonosító |
| 2 | Allobarbital (allobarbitál) | 5,5-diallylbarbituric acid | C10H12N2O3 | FDQGNLOWMMVRQL- UHFFFAOYSA-N | |
| 3 | Alprazolam (alprazolám) | 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3a][1,4]benzodiazepine | C17H13ClN4 | VREFGVBLTWBCJP- UHFFFAOYSA-N | |
| 4 | Amfepramone (amfepramon) | diethylpropion | 2-(diethylamino)propiophenone | C13H19NO | XXEPPPIWZFICOJ- UHFFFAOYSA-N |
| 5 | Aminorex (aminorex) | 2-amino-5-phenyl-2-oxazoline | C9H10N2O | SYAKTDIEAPMBAL- UHFFFAOYSA-N | |
| 6 | Barbital (barbital) | 5,5-diethylbarbituric acid | C8H12N2O3 | FTOAOBMCPZCFFF- UHFFFAOYSA-N | |
| 7 | Benzfetamine (benzfetamin) | benzphetamine | N-benzyl-N,α-dimethylphenethylamine | C17H21N | YXKTVDFXDRQTKV- UHFFFAOYSA-N |
| 8 | Bromazepam (bromazepám) | 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2one | C14H10BrN3O | VMIYHDSEFNYJSL- UHFFFAOYSA-N | |
| 9 | Brotizolam (brotizolám) | 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-striazolo[4,3-a][1,4]diazepine | C15H10BrClN4S | UMSGKTJDUHERQW- UHFFFAOYSA-N | |
| 10 | Butobarbital (butobarbitál) | 5-butyl-5-ethylbarbituric acid | C10H16N2O3 | STD BAQMTJ LUM FW- UHFFFAOYSA-N | |
| 11 | Camazepam (kamazepám) | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one dimethylcarbamate (ester) | C19H18ClN3O3 | PXBVEXGRHZFEOF- UHFFFAOYSA-N | |
| 12 | Chlordiazepoxide (klórdiazepoxid) | 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine4-oxide | C16H14ClN3O | ANTSCNMPPGJYLG- UHFFFAOYSA-N | |
| 13 | Clobazam (klobazám) | 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine2,4(3H,5H)-dione | C16H13ClN2O2 | CXOXHMZGEKVPMT- UHFFFAOYSA-N |
| 14 | Clonazepam (klonazepám) | 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4benzodiazepin-2-one | C15H10ClN3O3 | DGBIGWXXNGSACT- UHFFFAOYSA-N | |
| 15 | Clonazolam (klonazolám) | 6-(2-chlorophenyl)-1-methyl-8-nitro-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H12ClN5O2 | XJRGLCAWBRZUFC- UHFFFAOYSA-N | |
| 16 | Clorazepate (klorazepát) | 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4benzodiazepine-3-carboxylic acid | C16H11ClN2O3 | XDDJGVMJFWAHJX- UHFFFAOYSA-N | |
| 17 | Clotiazepam (klotiazepám) | 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2Hthieno[2,3-e]-1,4-diazepin-2-one | C16H15ClN2OS | CHBRHODLKOZEPZ- UHFFFAOYSA-N | |
| 18 | Cloxazolam (kloxazolám) | 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one | C17H14Cl2N2O2 | ZIXNZOBDFKSQTC- UHFFFAOYSA-N | |
| 19 | Delorazepam (delorazepám) | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4benzodiazepin-2-one | C15H10Cl2N2O | CHIFCDOIPRCHCF- UHFFFAOYSA-N | |
| 20 | Diazepam (diazepám) | 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one | C16H13ClN2O | AAOVKJBEBIDNHE- UHFFFAOYSA-N | |
| 21 | Diclazepam (diklazepám) | 2-chlorodiazepam, Ro5-3448 | 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2Hbenzo[e][1,4]diazepin-2-one | C16H12Cl2N2O | VPAYQWRBBOGGPY- UHFFFAOYSA-N |
| 22 | Estazolam (esztazolám) | 8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | C16H11ClN4 | CDCHDCWJMGXXRH- UHFFFAOYSA-N | |
| 23 | Ethchlorvynol (etklórvinol) | 1-chloro-3-ethyl-1-penten-4-yn-3-ol | C7H9ClO | ZEHYJZXQEQOSON- UHFFFAOYSA-N | |
| 24 | Ethinamate (etinamát) | 1-ethynylcyclohexanolcarbamate | C9H13NO2 | GXRZIMHKGDIBEW- UHFFFAOYSA-N | |
| 25 | Ethyl loflazepate (etil-loflazepát) | ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4benzodiazepine-3-carboxylate | C18H14ClFN2O3 | CUCHJCMWNFEYOM- UHFFFAOYSA-N | |
| 26 | Etilamfetamine (etilamfetamin) | N-ethylamphetamine | N-ethyl-α-methylphenethylamine | C11H17N | YAGBSNMZQKEFCO- UHFFFAOYSA-N |
| 27 | Etizolam (etizolám) | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H15ClN4S | VMZUTJCNQWMAGF- UHFFFAOYSA-N | |
| 28 | Fencamfamin (fenkamfamin) | N-ethyl-3-phenyl-2-norbornanamine | C15H21N | IKFBPFGUINLYQI- UHFFFAOYSA-N | |
| 29 | Fenproporex (fenproporex) | (±)-3-[(α-methylphenylethyl)amino]propionitrile | C12H16N2 | IQUFSXIQAFPIMR- UHFFFAOYSA-N | |
| 30 | Flualprazolam (flualprazolám) | 8-chloro-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H12ClFN4 | MPZVLJCMGPYWQQ- UHFFFAOYSA-N | |
| 31 | Flubromazolam (flubromazolám) | 8-bromo-6-(2-fluorophenyl)-1-methyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H12BrFN4 | VXGSZBZQCBNUIP- UHFFFAOYSA-N | |
| 32 | Fludiazepam (fludiazepám) | 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4benzodiazepin-2-one | C16H12ClFN2O | ROYOYTLGDLIGBX- UHFFFAOYSA-N | |
| 33 | Flurazepam (flurazepám) | 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3dihydro-2H-1,4-benzodiazepin-2-one | C21H23ClFN3O | SAADBVWGJQAEFS- UHFFFAOYSA-N |
| 34 | Halazepam (halazepám) | 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H- 1,4-benzodiazepin-2-one | C17H12ClF3N2O | WYCLKVQLVUQKNZ- UHFFFAOYSA-N | |
| 35 | Haloxazolam (haloxazolám) | 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b- tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one | C17H14BrFN2O2 | XDKCGKQHVBOOHC- UHFFFAOYSA-N | |
| 36 | Ketazolam (ketazolám) | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione | C20H17ClN2O3 | PWAJCNITSBZRBL- UHFFFAOYSA-N | |
| 37 | Lefetamine (lefetamin) | SPA | (–)-N,N-dimethyl-1,2-diphenylethylamine | C16H19N | YEJZJVJJPVZXGX- MRXNPFEDSA-N |
| 38 | Loprazolam (loprazolám) | 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1piperazinyl)methylene]-8-nitro-1H-imidazo[1,2a][1,4]benzodiazepin-1-one | C23H21ClN6O3 | UTEFBSAVJNEPTR- RGEXLXHISA-N | |
| 39 | Lorazepam (lorazepám) | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4benzodiazepin-2-one | C15H10Cl2N2O2 | DIWRORZWFLOCLC- UHFFFAOYSA-N | |
| 40 | Lormetazepam(lormetazepám) | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1methyl-2H-1,4-benzodiazepin-2-one | C16H12Cl2N2O2 | FJIKWRGCXUCUIG- UHFFFAOYSA-N | |
| 41 | Mazindol (mazindol) | 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1- a]isoindol5-ol | C16H13ClN2O | ZPXSCAKFGYXMGA- UHFFFAOYSA-N | |
| 42 | Medazepam (medazepám) | 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4benzodiazepine | C16H15ClN2 | YLCXGBZIZBEVPZ- UHFFFAOYSA-N | |
| 43 | Mefenorex (mefenorex) | N-(3-chloropropyl)-α-methylphenethylamine | C12H18ClN | XXVROGAVTTXONC- UHFFFAOYSA-N | |
| 44 | Meprobamate (meprobamát) | 2-methyl-2-propyl-1,3-propanedioldicarbamate | C9H18N2O4 | NPPQSCRMBWNHMW- UHFFFAOYSA-N | |
| 45 | Mesocarb (mezokarb) | 3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine | C18H18N4O2 | OWFUPROYPKGHMH- UHFFFAOYSA-N | |
| 46 | Methylphenobarbital (metilfenobarbitál) | 5-ethyl-1-methyl-5-phenylbarbituric acid | C13H14N2O3 | ALARQZQTBTVLJV- UHFFFAOYSA-N | |
| 47 | Methyprylon (metiprilon) | 3,3-diethyl-5-methyl-2,4-piperidine-dione | C10H17NO2 | SIDLZWOQUZRBRU- UHFFFAOYSA-N | |
| 48 | Midazolam (midazolám) | 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine | C18H13ClFN3 | DDLIGBOFAVUZHB- UHFFFAOYSA-N | |
| 49 | Nimetazepam (nimetazepám) | 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4benzodiazepin-2-one | C16H13N3O3 | GWUSZQUVEVMBPI- UHFFFAOYSA-N | |
| 50 | Nitrazepam (nitrazepám) | 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one | C15H11N3O3 | KJONHKAYOJNZEC- UHFFFAOYSA-N | |
| 51 | Nordazepam (nordazepám) | 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one | C15H11ClN2O | AKPLHCDWDRPJGD- UHFFFAOYSA-N | |
| 52 | Oxazepam (oxazepám) | 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4benzodiazepin-2-one | C15H11ClN2O2 | ADIMAYPTOBDMTL- UHFFFAOYSA-N |
| 53 | Oxazolam (oxazolám) | 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11bphenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one | C18H17ClN2O2 | VCCZBYPHZRWKFY- UHFFFAOYSA-N | |
| 54 | Pemoline (pemolin) | 2-amino-5-phenyl-2-oxazolin-4-one | C9H8N2O2 | NRNCYVBFPDDJNE- UHFFFAOYSA-N | |
| 55 | Phendimetrazine (fendimetrazin) | (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine | C12H17NO | MFOCDFTXLCYLKU- CMPLNLGQSA-N | |
| 56 | Phenobarbital (fenobarbitál) | 5-ethyl-5-phenylbarbituric acid | C12H12N2O3 | DDBREPKUVSBGFI- UHFFFAOYSA-N | |
| 57 | Phentermine (fentermin) | α,α-dimethylphenethylamine | C10H15N | DHHVAGZRUROJKS- UHFFFAOYSA-N | |
| 58 | Pinazepam (pinazepám) | 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4benzodiazepin-2-one | C18H13ClN2O | MFZOSKPPVCIFMT- UHFFFAOYSA-N | |
| 59 | Pipradrol (pipradrol) | 1,1-diphenyl-1-(2-piperidyl)methanol | C18H21NO | XSWHNYGMWWVAIE- UHFFFAOYSA-N | |
| 60 | Prazepam (prazepám) | 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H1,4-benzodiazepin-2-one | C19H17ClN2O | MWQCHH ACWWAQ LJ - UHFFFAOYSA-N | |
| 61 | Pyrovalerone (pirovaleron) | 4’-methyl-2-(1-pyrrolidinyl)valerophenone | C16H23NO | SWUVZKWCOBGPTH- UHFFFAOYSA-N | |
| 62 | Secbutabarbital (szekbutabarbitál) | 5-sec-butyl-5-ethylbarbituric acid | C10H16N2O3 | ZRIHAIZYIMGOAB- UHFFFAOYSA-N | |
| 63 | Temazepam (temazepám) | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one | C16H13ClN2O2 | SEQDDYPDSLOBDC- UHFFFAOYSA-N | |
| 64 | Tetrazepam (tetrazepám) | 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4benzodiazepin-2-one | C16H17ClN2O | IQWYAQCHYZHJOS- UHFFFAOYSA-N | |
| 65 | Triazolam (triazolám) | 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3a][1,4] benzodiazepine | C17H12Cl2N4 | JOFWLTCLBGQGBO- UHFFFAOYSA-N | |
| 66 | Vinylbital (vinilbitál) | 5-(1-methylbutyl)-5-vinylbarbituric acid | C11H16N2O3 | KGKJZEKQJQQOTD- UHFFFAOYSA-N | |
| 67 | Zolpidem (zolpidem) | N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide | C19H21N3O | ZAFYATHCZYHLPB- UHFFFAOYSA-N |
4.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek, és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, amennyiben ilyen sók léteznek.
4.3. Jelen P4 jegyzék a Pszichotróp Egyezmény aktualizált IV. listája alapján készült"
3. melléklet a 31/2023. (VIII. 22.) BM rendelethez
1. Az R. 3. melléklet 6. pont 6.1. alpontja helyébe a következő alpont lép:
(Az 1-5. pontban foglaltakon túlmenően továbbá)
"6.1. a következő vegyületek:
| A | B | C | D | |
| 1 | Hivatalos elnevezés (illetve más név vagy rövidítés, illetve külföldön gyakran használt más írásmód) | Kémiai név | Összegképlet | InChIKey kémiai azonosító |
| 2 | 2C-B-BZP | 1-(4-bromo-2,5-dimethoxybenzyl)-4-piperazine | C13H19BrN2O2 | OHXVYXBOJDDYJS- UHFFFAOYSA-N |
| 3 | CPCPP, Gelbes | 1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine | C13H18Cl2N2 | NDQKGEFMUGSRNS- UHFFFAOYSA-N |
| 4 | Dichlorophenyl-piperazine (diklórfenil- piperazin) | 1-(2,3-dichlorophenyl)piperazine | C10H12Cl2N2 | UDQMXYJSNNCRAS- UHFFFAOYSA-N |
| 5 | Harmin (harmine) | 7-methoxy-1-methyl-9H-β-carboline | C13H12N2O | BXNJHAXVSOCGBA- UHFFFAOYSA-N |
| 6 | 5-MeO-triptamin (5-MeO-tryptamine) | 2-(5-methoxy-1H-indol-3-yl)ethanamine | C11H14N2O | JTEJPPKMYBDEMY- UHFFFAOYSA-N |
| 7 | N-benzyl-1-PEA (N-benzil-1-PEA) | N-benzyl-1-phenylethanamine | C15H17N | ZYZHMSJNPCYUTB- UHFFFAOYSA-N |
| 8 | pCPP | 1-(4-chlorophenyl)piperazine | C10H13ClN2 | UNEIHNMKASENIG- UHFFFAOYSA-N |
| 9 | 1-phenyl-propyl-amine (fenilpropilamin, 1- phenyl-1 -propanamine) | 1-phenylpropan-1-amine | C9H13N | AQFLVLHRZFLDDV- UHFFFAOYSA-N |
| 10 | pMeOPP | 1-(4-methoxyphenyl)piperazine | C11H16N2O | MRDGZSKYFPGAKP- UHFFFAOYSA-N |
| 11 | URB-754 | 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one | C16H14N2O2 | GFWNGVKCDGYFKG- UHFFFAOYSA-N |
| 12 | RH-34 | 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione | C18H19N3O3 | NUAJBITWGGTZCM- UHFFFAOYSA-N |
| 13 | MEOP; Methoxypiperamide; metoxipiperamid; MEXP; 1(4methoxybenzoyl)-4-methylpiperazine | (4-methoxyphenyl)(4-methylpiperazin-1-yl)methanone | C13H18N2O2 | DWPVVZZGGGCRRM- UHFFFAOYSA-N |
| 14 | bk-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone | C10H12BrNO3 | HFYJGAIOBIDRPX- UHFFFAOYSA-N |
| 15 | 25I-NBF | 2-(4-iodo-2,5-dimethoxyphenyl)- N-[(2-fluorophenyl)methyl]ethanamine | C17H19FINO2 | LPBKNBHMWRBPHT- UHFFFAOYSA-N |
| 16 | Mexedrone; 4-MMC-oMe; ’MEX’ | 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | C12H17NO2 | JHGDCSPZKQLBOP- UHFFFAOYSA-N |
| 17 | TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan1-one | C19H27NO | MMIKQWIZKBYLKZ- UHFFFAOYSA-N |
| 18 | izopropilfenidát (isopropylphenidate) | propan-2-yl phenyl(piperidin-2-yl)acetate | C16H23NO2 | AZVPADMEIMLODT- UHFFFAOYSA-N |
| 19 | metamnetamin (methylnaphetamine; Nmethyl- PAL-287; MNT; MNA) | N-methyl-1-(naphthalen-2-yl)propan-2-amine | C14H17N | BWWWOLYZMKACSB- UHFFFAOYSA-N |
| 20 | dezklórketamin (deschloroketamine; 2-(phenyl)-2-(methylamino)cyclohexanone) | 2-(methylamino)-2-phenylcyclohexanone | C13H17NO | ZAGBSZSITDFFAF- UHFFFAOYSA-N |
| 21 | 1P-LSD (1-propionyl-d-lysergic acid diethylamide) | N,N-diethyl-7-methyl-4-propanoyl-6,6a,8, 9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide | C23H29N3O2 | JSMQOVGXBIDBIE- UHFFFAOYSA-N |
| 22 | Ethylnaphthidate; HDEP-28 | ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate | C19H23NO2 | OTQVTBPHZRARTL- UHFFFAOYSA-N |
| 23 | 4-methylmethylphenidate; 4Me-TMP | methyl 2-(piperidin-2-yl)-2-(p-tolyl)acetate | C15H21NO2 | WJZNCJIOIACDBR- UHFFFAOYSA-N |
| 24 | 4-fluoromethylphenidate; 4F-TMP; 4F-MPH; 4-FMPH | methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | C14H18FNO2 | XISBAJBPDVRSPG- UHFFFAOYSA-N |
| 25 | CUMYL-5F-P7AICA; CUMYL-5F-PAICA; SGT263 | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3b]pyridine-3-carboxamide | C22H26FN3O | MXJYOUMYJGNQEY- UHFFFAOYSA-N |
| 26 | (Iso)butyryl-F-fentanyl N-benzyl analogue | 2-methyl-N-(1-benzylpiperidin-4-yl)-N-(4fluorophenyl)propanamide | C22H27FN2O | XNQGKYHSTDKIKG- UHFFFAOYSA-N |
| 27 | Despropionyl-2-fluoro fentanyl; despropionyl-o-fluoro fentanyl | N-(2-fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine | C19H23FN2 | WUNLGTOLOUTCPE- UHFFFAOYSA-N |
| 28 | Flubromazepam | 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4- benzodiazepin-2-one | C15H10BrFN2O | ZRKDDZBVSZLOFS- UHFFFAOYSA-N |
| 29 | 5-fluoropentyl-3-pyridinoylindole | [1-(5-fluoropentyl)-1H-indol-3-yl](pyridin-3-yl)methanone | C19H19FN2O | CNMQLCYLJPWHEW- UHFFFAOYSA-N |
| 30 | Phenibut | 4-amino-3-phenylbutanoic acid | C10H13NO2 | DAFOCGYVTAOKAJ- UHFFFAOYSA-N |
| 31 | 2-fluorodeschloroketamine; 2-Fl-2’-Oxo- PCM; fluoroketamine; 2-FDCK; 2F-DK; 2FDK; 2-FK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexanone | C13H16FNO | PHFAGYYTDLITTB- UHFFFAOYSA-N |
| 32 | Dichloropane; RTI-111; RTI-4229-111; O-401 | methyl 3-(3,4-dichlorophenyl)-8-methyl-8- azabicyclo[3.2.1]octane-2-carboxylate | C16H19Cl2NO2 | AMIHUYQKNJHXPT- UHFFFAOYSA-N |
| 33 | AMAPN | 2-(methylamino)-1-(naphthalen-1-yl)propan-1-one | C14H15NO | QIACKSHQBOUATI- UHFFFAOYSA-N |
| 34 | 5Cl-bk-MPA; 5Cl-bkmethylthienylpropamine; 5Cl-bk-methiopropamine | 1-(5-chlorothiophen-2-yl)-2-(methylamino)propan-1-one | C8H10ClNOS | VTSPXQPERGVFBV- UHFFFAOYSA-N |
| 35 | 5F-Cumyl-PeGaClone; 5F-SGT-151 | 5-(5-fluoropentyl)-2-(2-phenylpropan-2-yl)-2,5- dihydro-1H-pyrido[4,3-b]indol-1-one | C25H27FN2O | SMRRORRDOWXERZ- UHFFFAOYSA-N |
| 36 | ALD-52; 1-acetyl-LSD | (6aR,9R)-4-acetyl-N,N-diethyl-7-methyl- 6,6a,8,9-tetrahydroindolo[4,3-f,g]quinoline-9-carboxamide | C22H27N3O2 | FJOWXGYLIWJFCH- OXQOHEQNSA-N |
| 37 | ETH-LAD; 6-ethyl-6-nor-lysergic acid diethylamide | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3fg]quinoline-9-carboxamide | C21H27N3O | MYNOUXJLOHVSMQ- |
| DNVCBOLYSA-N | ||||
| 38 | diphenyl-PBP | 1-(1,3-diphenylpropan-2-yl)pyrrolidine | C19H23N | VQECHRQHFMUVRS- UHFFFAOYSA-N |
| 39 | benzoil-fentanil (benzoylfentanyl) | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]benzamide | C26H28N2O | BJPDWVPQDSVQKD- UHFFFAOYSA-N |
| 40 | Cumyl-CH-MegaClone | 5-cyclohexylmethyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1Hpyrido[4,3-b]indol-1-one | C27H30N2O | CGHCGYCTOLWAPL- UHFFFAOYSA-N |
| 41 | 1-Aminoindan | 2,3-dihydro-1H-inden-1-amine | C9H11N | XJEVHMGJSYVQBQ- UHFFFAOYSA-N |
| 42 | N-methyl-2AI | N-methyl-2,3-dihydro-1H-inden-2-amine | C10H13N | SXWZQUCTTOBHJT- UHFFFAOYSA-N |
| 43 | M-ALPHA | 1-(1,3-benzodioxol-5-yl)-N-methylpropan-1-amine | C11H15NO2 | NLINVDHEDVEOMJ- UHFFFAOYSA-N |
| 44 | Thiopropamine | 1-(thiophen-2-yl)propan-2-amine | C7H11NS | NYVQQTOGYLBBDQ- UHFFFAOYSA-N |
| 45 | 2-APB | 1-(1-benzofuran-2-yl)propan-2-amine | C11H13NO | QGLBWEFCBFEAPH- UHFFFAOYSA-N |
| 46 | 2-MAPB | 1-(1-benzofuran-2-yl)-N-methylpropan-2-amine | C12H15NO | ANJIDHKQUCZNQY- UHFFFAOYSA-N |
| 47 | 2-EAPB | 1-(1-benzofuran-2-yl)-N-ethylpropan-2-amine | C13H17NO | SGGKRTSTBXBERJ- UHFFFAOYSA-N |
| 48 | 5-MeO-DIBF | N-[2-(5-methoxy-1-benzofuran-3-yl)ethyl]-N-(propan-2yl)propan-2-amine | C17H25NO2 | NBFMSQBTYHYVKP- UHFFFAOYSA-N |
| 49 | 2-MABB | 1-(1-benzofuran-2-yl)-N-methylbutan-2-amine | C13H17NO | YBPPNDUCEMDPJZ- UHFFFAOYSA-N |
| 50 | 1-(4-Bromo-2,5- dimethoxyphenyl)ethanamine | 1-(4-bromo-2,5-dimethoxyphenyl)ethanamine | C10H14BrNO2 | JKOMOTQHGDWZAQ- UHFFFAOYSA-N |
| 51 | BOH-PHP | 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-ol | C16H25NO | GJHNPZVIGWPXBH- UHFFFAOYSA-N |
| 52 | 2-MeO-Ketamine | 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone | C14H19NO2 | OYAUVHORXFUVAJ- UHFFFAOYSA-N |
| 53 | Methoxetamine brominated derivative | 2-(2-bromo-5-methoxyphenyl)-2-(ethylamino)cyclohexanone | C15H20BrNO2 | YNEMYNGTFPWRHN- UHFFFAOYSA-N |
| 54 | 3MeO-PCMo | 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine | C17H25NO2 | BOGOEDFWPOXWQE- UHFFFAOYSA-N |
| 55 | Benocyclidine | 1-[1-(benzothiophen-2-yl)cyclohexyl]piperidine | C19H25NS | RGSVXQJPSWZXOP- UHFFFAOYSA-N |
| 56 | Tiletamine | 2-(ethylamino)-2-(2-thienyl)cyclohexanone | C12H17NOS | QAXBVGVYDCAVLV- UHFFFAOYSA-N |
| 57 | deschloro-N-ethyl-ketamine (O-PCE) | 2-(ethylamino)-2-phenyl-cyclohexanone | C14H19NO | IDLSBAANXISGEI- UHFFFAOYSA-N |
| 58 | 3-MeO-PCMMo | 4-([1-(3-methoxyphenyl)cyclohexyl]methyl)morpholine | C18H27NO2 | KVDDTOKOCUZIFC- UHFFFAOYSA-N |
| 59 | 3-HO-PCE | 3-[1-(ethylamino)cyclohexyl]phenol | C14H21NO | MIKNPNLBFHVMKK- UHFFFAOYSA-N |
| 60 | 3-HO-PCP | 3-(1-piperidin-1-ylcyclohexyl)phenol | C17H25NO | AMSXTZUCNOKUEN- UHFFFAOYSA-N |
| 61 | Methoxpropamine | 2-(3-methoxyphenyl)-2-(propylamino)cyclohexan-1-one | C16H23NO2 | AAVOSBAXDRASAH- UHFFFAOYSA-N |
| 62 | Pyrazolam | 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | C16H12BrN5 | BGRWSFIQQPVEML- UHFFFAOYSA-N |
| 63 | Alprazolam triazolobenzophenone derivative | (2-[3-(aminomethyl)-5-methyl-4H-1,2,4-triazol-4-yl]-5chlorophenyl)phenyl-methanone | C17H15ClN4O | WWADXOXMCNJJKR- UHFFFAOYSA-N |
| 64 | Meclonazepam | 5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4benzodiazepin-2-one | C16H12ClN3O3 | LMUVYJCAFWGNSY- UHFFFAOYSA-N |
| 65 | Deschloroetizolam | 2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3a][1,4]diazepine | C17H16N4S | JIOBORXCOGMHSV- UHFFFAOYSA-N |
| 66 | Nifoxipam | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4benzodiazepin-2-one | C15H10FN3O4 | UHFIFTRHLBAWGY- UHFFFAOYSA-N |
| 67 | Adinazolam | 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine | C19H18ClN5 | GJSLOMWRLALDCT- UHFFFAOYSA-N |
| 68 | Metizolam | 4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3a][1,4]diazepine | C16H13ClN4S | NQSSWDKQLVBUQN- UHFFFAOYSA-N |
| 69 | Nitrazolam | 1-methyl-8-nitro-6-phenyl-4H-1,2,4]triazolo[4,3a][1,4]benzodiazepine | C17H13N5O2 | OYRPNABWTHDOFK- UHFFFAOYSA-N |
| 70 | Cloniprazepam | 5-(2-chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro2H-1,4-benzodiazepin-2-one | C19H16ClN3O3 | CCSYKGYLSFXNTA- UHFFFAOYSA-N |
| 71 | Cinazepam | 4-([7-bromo-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4- benzodiazepin-3-yl]oxy)-4-oxo-butanoic acid | C19H14BrClN2O5 | NQTRBZXDWM DXAQ- UHFFFAOYSA-N |
| 72 | 3-hydroxyphenazepam | 7-bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4- benzodiazepin-2-one | C15H10BrClN2O2 | KRJKJUWAZOWXNV- UHFFFAOYSA-N |
| 73 | Fonazepam | 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2one | C15H10FN3O3 | KNGIGRDYBQPXKQ- UHFFFAOYSA-N |
| 74 | 4-chlorodiazepam | 7-chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2one | C16H12Cl2N2O | PUMYFTJOWAJIKF- UHFFFAOYSA-N |
| 75 | Flunitrazolam | 6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | C17H12FN5O2 | RDLAGIOILLWVTM- UHFFFAOYSA-N |
| 76 | Bromazolam | 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | C17H13BrN4 | KCEIOBKDDQAYCM- UHFFFAOYSA-N |
| 77 | Norfludiazepam | 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2one | C15H10ClFN2O | UVCOILFBWYKHHB- UHFFFAOYSA-N |
| 78 | Ro 07-4065 | 7-chloro-5-(2,6-difluorophenyl)-1-methyl-3H-1,4benzodiazepin-2-one | C16H11ClF2N2O | DUNFPASORLTEGN- UHFFFAOYSA-N |
| 79 | Thionordazepam | 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione | C15H11ClN2S | ULILTJWAJZIROM- UHFFFAOYSA-N |
| 80 | Methyl clonazepam | 5-(2-chlorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2one | C16H12ClN3O3 | AZVBJJDUDXZLTM- UHFFFAOYSA-N |
| 81 | Fluclotizolam | 2-chloro-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine | C15H10ClFN4S | ZDYRCUZZLRLMHG- UHFFFAOYSA-N |
| 82 | Clobromazolam | 8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine | C17H12BrClN4 | BUTCFAZTKZDYCN- UHFFFAOYSA-N |
| 83 | Bentazepam | 5-phenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3e][1,4]diazepin-2-one | C17H16N2OS | AIZFEOPQVZBNGH- UHFFFAOYSA-N |
| 84 | CP 47,497 | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol | C21H34O2 | ZWWRREXSUJTKNN- AEFFLSMTSA-N |
| 85 | AM-1220 Azepane Isomer | [1-(hexahydro-1-methyl-1H-azepin-3-yl)-1H-indol-3-yl]-1naphthalenyl-methanone | C26H26N2O | ZDCZZWAEXISRJF- UHFFFAOYSA-N |
| 86 | Org 27569 | 5-chloro-3-ethyl-N-[2-[4-(1-piperidinyl)phenyl]ethyl]-1H-indole2-carboxamide | C24H28ClN3O | AHFZDNYNXFMRFQ- UHFFFAOYSA-N |
| 87 | Org 27759 | N-[2-[4-(dimethylamino)phenyl]ethyl]-3-ethyl-5-fluoro-1Hindole-2-carboxamide | C21H24FN3O | MUYUEZAKMLKZSO- UHFFFAOYSA-N |
| 88 | Org 29647 | N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2carboxamide | C22H24ClN3O | MYJJVFCPCDPOSM- UHFFFAOYSA-N |
| 89 | HU-331 | 3-hydroxy-2-(6-isopropenyl-3-methyl-cyclohex-2-en-1-yl)-5pentyl-1,4-benzoquinone | C21H28O3 | WDXXEUARVHTWQF- UHFFFAOYSA-N |
| 90 | WIN 55212-2 | [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1naphthalen-1-yl-methanone | C27H26N2O3 | HQVHOQAKMCMIIM- HXUWFJFHSA-N |
| 91 | AB-005 azepane isomer | [1-(1-methylazepan-2-yl)indol-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone | C23H32N2O | VBJJSVQSAWSBQA- UHFFFAOYSA-N |
| 92 | 4-HTMPIPO | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1one | C21H31NO2 | GWHGUYKAGQLPTQ- UHFFFAOYSA-N |
| 93 | URB-597 | 3’-carbamoylbiphenyl-3-yl cyclohexylcarbamate | C20H22N2O3 | ROFVXGGUISEHAM- UHFFFAOYSA-N |
| 94 | JTE-907 | N-(1,3-benzodioxol-5-ylmethyl)-2-hydroxy-7-methoxy-8pentoxy-quinoline-3-carboxamide | C24H26N2O6 | GRAJFFFXJYFVOC- UHFFFAOYSA-N |
| 95 | LY2183240 | 5-([1,1’-biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1carboxamide | C17H17N5O | GZNIYOXWFCDBBJ- UHFFFAOYSA-N |
| 96 | 1-(Cyclohexylmethyl)-2-[(4ethoxyphenyl)methyl]-N,N-diethyl-1Hbenzimidazol-5-carboxamide | 1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethylbenzimidazole-5-carboxamide | C28H37N3O2 | WRVZBXHTUOPQJS- UHFFFAOYSA-N |
| 97 | AM-2201 benzimidazole analogue (FUBIMINA) | [1-(5-fluoropentyl)-1H-benzimidazol-2-yl](naphthalen-1yl)methanone | C23H21FN2O | KUESSZM ROAFKQJ- UHFFFAOYSA-N |
| 98 | 5F-AB-FUPPYCA (5F-5,3-AB-PFUPPYCA) | 2-([1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazol-3yl]formamido)-3-methylbutanamide | C20H26F2N4O2 | GSXRDTDYPSATDE- UHFFFAOYSA-N |
| 99 | 5F-PY-PICA | [1-(5-fluoropentyl)-1H-indol-3-yl](pyrrolidin-1-yl)methanone | C18H23FN2O | AJOAHRJLOXOZKX- UHFFFAOYSA-N |
| 100 | 5F-PY-PINACA | [1-(5-fluoropentyl)-1H-indazol-3-yl](pyrrolidin-1-yl)methanone | C17H22FN3O | GSCLIRQNUBFUJA- UHFFFAOYSA-N |
| 101 | AB-CHMFUPPYCA (3,5-AB-CHMFUPPYCA) | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3(4-fluorophenyl)-1H-pyrazole-5-carboxamide | C22H29FN4O2 | NDYOOVJIZQTGHY- UHFFFAOYSA-N |
| 102 | MDMB-CHMCZCA | 9-(cyclohexylmethyl)-N-(1-methoxycarbonyl- 2,2-dimethyl-propyl)carbazole-3-carboximidic acid | C27H34N2O3 | FAWVRKNYDPKTDZ- UHFFFAOYSA-N |
| 103 | 5F-PCN | 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2c]pyridine-3-carboxamide | C23H22FN3O | BRRZRRZUERBDQL- UHFFFAOYSA-N |
| 104 | EG-2201 | [9-(5-fluoropentyl)-9H-carbazol-3-yl](naphthalen-1yl)methanone | C28H24FNO | LYDDINAZVHIBGP- UHFFFAOYSA-N |
| 105 | MDA 19 (BZO-HEXOXIZID) | N-[(Z)-(1-hexyl-2-oxo-indolin-3-ylidene)amino]benzamide | C21H23N3O2 | ZGQHMZCITJHYOW- QOCHGBHMSA-N |
| 106 | MO-CHMINACA | 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate | C22H30N2O4 | SUEOBRAXHJBVGY- UHFFFAOYSA-N |
| 107 | MDMB-PCZCA | methyl 3,3-dimethyl-2-[(9-pentylcarbazole-3-carbonyl)amino] butanoate | C25H32N2O3 | GILRPTXNJMVJBM- UHFFFAOYSA-N |
| 108 | 5F-3,5-AB-PFUPPYCA | N-(1-carbamoyl-2-methyl-propyl)-1-(5-fluoropentyl)-3-(4- fluorophenyl)pyrazole-5-carboxamide | C20H26F2N4O2 | JPKXVUNTSWGYKJ- UHFFFAOYSA-N |
| 109 | CUMYL-4CN-B7AICA | 1-(4-cyanobutyl)-N-(1-methyl-1-phenyl-ethyl)pyrrolo[2,3b]pyridine-3-carboxamide | C22H24N4O | DYPZVGXELGJCHD- UHFFFAOYSA-N |
| 110 | 5F-MDMB-P4AICA | methyl 2-([1-(5-fluoropentyl)pyrrolo[3,2-b]pyridine-3carbonyl]amino)-3,3-dimethyl-butanoate | C20H28FN3O3 | YUNKAZHULJISDA- UHFFFAOYSA-N |
| 111 | 5F-MDMB-P7AICA | methyl 2-([1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3yl]formamido)-3,3-dimethylbutanoate | C20H28FN3O3 | LIRBKFHBIDESHO- UHFFFAOYSA-N |
| 112 | 5F-AB-P7AICA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1Hpyrrolo[2,3-b]pyridine-3-carboxamide | C18H25FN4O2 | PEAJNPAIVYHNDQ- UHFFFAOYSA-N |
| 113 | 2F-QMPSB | quinolin-8-yl 3-[(4,4-difluoropiperidin-1-yl) sulfonyl]-4-methylbenzoate | C22H20F2N2O4S | JOSWCKYCXJMLNM- UHFFFAOYSA-N |
| 114 | 5F-A-P7AICA | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3b]pyridine-3-carboxamide | C23H30FN3O | JYMCNFJJLBFSGH- UHFFFAOYSA-N |
| 115 | 3’,4’-Methylenedioxy-alpha-methylPPP (MDMPP) | 1-(1,3-benzodioxol-5-yl)-2-methyl-2-(pyrrolidin-1-yl)propan-1one | C15H19NO3 | QEVPOSURBZYOOK- UHFFFAOYSA-N |
| 116 | 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2(pyrrolidinyl-1-yl)ethan-1-one | 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidin-1yl)ethanone | C21H23NO | JFDZZTSFBTYYDF- UHFFFAOYSA-N |
| 117 | alpha-PPP-MeO | 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | C14H19NO2 | TVBNCCGCIPGJQO- UHFFFAOYSA-N |
| 118 | 3,4-Dichloro-N,N-cyclohexylmethylmethcathinone | 2-[cyclohexyl(methyl)amino]-1-(3,4-dichlorophenyl)propan-1one | C16H21Cl2NO | YOJYFWVGILSSIW- UHFFFAOYSA-N |
| 119 | TH-PBP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)butan-1one | C18H25NO | DNKYSKGKPOHTKY- UHFFFAOYSA-N |
| 120 | alpha-pyrrolidinocyclohexylphenone (alpha-PCYP) | 2-cyclohexyl-1-phenyl-2-(pyrrolidin-1-yl)ethan-1-one | C18H25NO | FKEHRWJWTWDTDB- UHFFFAOYSA-N |
| 121 | 2-Me-DMT | N,N-dimethyl-2-(2-methyl-1H-indol-3-yl)ethanamine | C13H18N2 | NDGCOWDSLVNLGE- UHFFFAOYSA-N |
| 122 | AL-LAD | (8β)-9,10-didehydro-N,N-diethyl-6-(2-propenyl)-ergoline-8carboxamide | C22H27N3O | JCQLEPDZFXGHHQ- OXQOHEQNSA-N |
| 123 | McPT | N-[2-(1H-indol-3-yl)ethyl]-N-methylcyclopropanamine | C14H18N2 | LVOSBNVSQLXACL- UHFFFAOYSA-N |
| 124 | alpha-TMT | 1-(1H-indol-3-yl)-N,N-dimethylpropan-2-amine | C13H18N2 | XQFCCTPWINMCQJ- UHFFFAOYSA-N |
| 125 | 1P-ETH-LAD | N,N,7-triethyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3fg]quinoline-9-carboxamide | C24H31N3O2 | MLOFCBXSOAYCIF- UHFFFAOYSA-N |
| 126 | 5-MeO-pyr-T | 5-methoxy-3-(2-pyrrolidin-1-ylethyl)-1H-indole | C15H20N2O | KAASYKNZNPWPQG- UHFFFAOYSA-N |
| 127 | Lysergic acid methyl ester | methyl 7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3fg]quinoline-9-carboxylate | C17H18N2O2 | RNHDWLRHUJZABX- UHFFFAOYSA-N |
| 128 | 4-HO-McPT | 3-(2-[cyclopropyl(methyl)amino]ethyl)-1H-indol-4-ol | C14H18N2O | GFVJBFIXZYLVPO- UHFFFAOYSA-N |
| 129 | 4-PrO-DMT | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl propanoate | C15H20N2O2 | KUOGXPDQORRHED- UHFFFAOYSA-N |
| 130 | Butorphanol | 17-(cyclobutylmethyl)morphinan-3,14-diol | C21H29NO2 | IFKLAQQSCNILHL- QHAWAJNXSA-N |
| 131 | U-49900 | 3,4-dichloro-N-[2-(diethylamino)cyclohexyl]- N-methylbenzamide | C18H26Cl2N2O O | AXACJBKFKCCIOR- UHFFFAOYSA-N |
| 132 | U-51754 | 2-(3,4-dichlorophenyl)-N-[2-(dimethylamino)cyclohexyl]-Nmethyl-acetamide | C17H24Cl2N2O | ISJUYFBACBKWBV- UHFFFAOYSA-N |
| 133 | Benzodioxole-fentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]-1,3-benzodioxole-5carboxamide | C27H28N2O3 | ZFAAZMIOHJNKGD- UHFFFAOYSA-N |
| 134 | 3-phenylpropanoylfentanyl | N,3-diphenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide | C28H32N2O | DIRAGWDYMRIDIO- UHFFFAOYSA-N |
| 135 | Tetramethylcyclopropanefentanyl | 2,2,3,3-tetramethyl-N-phenyl-N-[1-(2-phenylethyl)-4piperidyl]cyclopropanecarboxamide | C27H36N2O | BYCDH AVF KDTVAM - UHFFFAOYSA-N |
| 136 | U-48800 | 2-(2,4-dichlorophenyl)-N-[2-(dimethylamino) cyclohexyl]-N-methyl-acetamide | C17H24Cl2N2O | FKUWIGXXBMULOI- UHFFFAOYSA-N |
| 137 | Thiophenefentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl] thiophene-2-carboxamide | C24H26N2OS | CCHPKGYUIHSQIE- UHFFFAOYSA-N |
| 138 | Benzylfentanyl | N-(1-benzyl-4-piperidyl)-N-phenyl-propanamide | C21H26N2O | POQDXIFVWVZVML- UHFFFAOYSA-N |
| 139 | Bromadoline | 4-bromo-N-[2-(dimethylamino)cyclohexyl]benzamide | C15H21BrN2O | UFDJFJYMMIZKLG- UHFFFAOYSA-N |
| 140 | Acetylbenzylfentanyl | N-(1-benzyl-4-piperidyl)-N-phenyl-acetamide | C20H24N2O | UKGXYSOSRSCGJB- UHFFFAOYSA-N |
| 141 | Benzoylbenzylfentanyl | N-(1-benzyl-4-piperidyl)-N-phenyl-benzamide | C25H26N2O | TVPYSIMEYHFHLN- UHFFFAOYSA-N |
| 142 | 4-hydroxybutyrfentanyl; 4-HO-BF | N-(4-hydroxyphenyl)-N-[1-(2-phenylethyl)piperidin-4yl]butanamide | C23H30N2O2 | HMPNQEXOJZKKKE- UHFFFAOYSA-N |
| 143 | isopropyl-U-47700 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2yl)benzamide | C18H26Cl2N2O | LGYQSYWASFBSHJ- UHFFFAOYSA-N |
| 144 | U-50488 | 2-(3,4-dichlorophenyl)-N-methyl-N-(2-pyrrolidin-1ylcyclohexyl)acetamide | C19H26Cl2N2O | VQLPLYSROCPWFF- UHFFFAOYSA-N |
| 145 | 3,4-methylenedioxy-U-47700 | N-[2-(dimethylamino)cyclohexyl]-N-methyl-1,3-benzodioxole-5carboxamide | C17H24N2O3 | UUAVKYBZWVMWSM- UHFFFAOYSA-N |
| 146 | 4-fluoro-cyclopropylbenzylfentanyl | N-(1-benzyl-4-piperidyl)-N-(4-fluorophenyl) cyclopropanecarboxamide | C22H25FN2O | DGFCHXNCEJHFDB- UHFFFAOYSA-N |
| 147 | Furanylbenzylfentanyl | N-(1-benzyl-4-piperidyl)-N-phenyl-furan-2-carboxamide | C23H24N2O2 | GDPJXHFICUEJBT- UHFFFAOYSA-N |
| 148 | 2-methylacetylfentanyl | N-(2-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide | C22H28N2O | GRDWUDZBHWHLSH- UHFFFAOYSA-N |
| 149 | N-methyl U-47931E | 4-bromo-N-[2-(dimethylamino)cyclohexyl]- N-methylbenzamide | C16H23BrN2O | XQCGUPNNNXRBDG- UHFFFAOYSA-N |
| 150 | Piperidylthiambutene | 1-[4,4-di(thiophen-2-yl)but-3-en-2-yl]piperidine | C17H21NS2 | FQRWJLVMJCKSME- UHFFFAOYSA-N |
| 151 | 2-methyl-AP-237 | 1-[2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]butan-1one | C18H26N2O | CRSFXYZFNAFVFC- UHFFFAOYSA-N |
| 152 | AP-237 | 1-[4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]butan-1-one | C17H24N2O | ZQBMUHABRSEAIK- UHFFFAOYSA-N |
| 153 | Furanyl UF-17 | N-[2-(dimethylamino)cyclohexyl]-N-phenyl-furan-2carboxamide | C19H24N2O2 | OSFBKUBOZUWERW- UHFFFAOYSA-N |
| 154 | 2F-viminol | 2-[di(butan-2-yl)amino]-1-[1-(2-fluorobenzyl)-1H-pyrrol-2yl]ethan-1-ol | C21H31FN2O | FXQMNNHPOYWWKI- UHFFFAOYSA-N |
| 155 | Iso-ethcathinone | 1-(ethylamino)-1-phenylpropan-2-one | C11H15NO | GHVCNLDRNVGRJP- UHFFFAOYSA-N |
| 156 | 5-HTP | 2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid | C11H12N2O3 | LDCYZAJDBXYCGN- UHFFFAOYSA-N |
| 157 | Ostarine | 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2hydroxy-2-methylpropanamide | C19H14F3N3O3 | JNGVJMBLXIUVRD- UHFFFAOYSA-N |
| 158 | 4-Fluoroephedrine | 4-fluoro-α-[1-(methylamino)ethyl]-benzenemethanol | C10H14FNO | SPEQHEOLWDGWML- UHFFFAOYSA-N |
| 159 | 4-methylphendimetrazine | 3,4-dimethyl-2-(4-methylphenyl)morpholine | C13H19NO | UJDFQROPBYDNBJ- UHFFFAOYSA-N |
| 160 | Mebroqualone | 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | C15H11BrN2O | NBUSAPJNASSKBP- UHFFFAOYSA-N |
| 161 | W-15 | 4-chloro-N-[(2E)-1-(2-phenylethyl)piperidin-2ylidene]benzenesulfonamide | C19H21ClN2O2S | VJHXSSVOCOBVMI- XUTLUUPISA-N |
| 162 | Sibutramine | 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine | C17H26ClN | UNAANXDKBXWMLN- UHFFFAOYSA-N |
| 163 | Embutramide | N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide | C17H27NO3 | LMBMDLOSPKIWAP- UHFFFAOYSA-N |
| 164 | Lysergic acid 2,4-dimethylazetidide (LSZ) | [(6aS,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3- f,g]quinoline-9-yl]-[(2S,4S)-2,4-dimethylazetidin-1-yl]methanone | C21H25N3O | DUKNIHFTDAXJON- UHFFFAOYSA-N |
| 165 | Noopept | ethyl (([(2S)-1-(phenylacetyl)pyrrolidin-2yl]carbonyl)amino)acetate | C17H22N2O4 | PJNSMUBMSNAEEN- AWEZNQCLSA-N |
| 166 | Mesembrine | 3a-(3,4-dimethoxyphenyl)- 1-methyl-2,3,4,5,7,7a- hexahydroindol-6-one | C17H23NO3 | DAHIQPJTGIHDGO- UHFFFAOYSA-N |
| 167 | Orphenadrine | N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine | C18H23NO | QVYRGXJJSLMXQH- UHFFFAOYSA-N |
| 168 | Ephenidine (NEDPA) | N-ethyl-1,2-diphenylethanamine | C16H19N | IGFZMQXEKIZPDR- UHFFFAOYSA-N |
| 169 | NPDPA | N-(1,2-diphenylethyl)propan-2-amine | C17H21N | FBRJTEBLJRHAQX- UHFFFAOYSA-N |
| 170 | W-18 | 4-chloro-N-((2E)-1-[2-(4-nitrophenyl)ethyl]piperidin-2ylidene)benzenesulfonamide | C19H20ClN3O4S | BKRSVROQVRTSND- XUTLUUPISA-N |
| 171 | Adrafinil | 2-[(diphenylmethyl)sulfinyl]-N-hydroxy-acetamide | C15H15NO3S | CGNMLOKEMNBUAI- UHFFFAOYSA-N |
| 172 | Afloqualone | 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4(3H)one | C16H14FN3O | VDOSWXIDETXFET- UHFFFAOYSA-N |
| 173 | Modafiendz | 2-([bis(4-fluorophenyl)methyl]sulfinyl)-N-methylacetamide | C16H15F2NO2S | MQZWTCIUDSDFCQ- UHFFFAOYSA-N |
| 174 | Methylmethaqualone | 3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one | C17H16N2O | MPMDMUROZIYIIM- UHFFFAOYSA-N |
| 175 | Flibanserin | 1,3-dihydro-1-(2-(4-[3-(trifluoromethyl)phenyl]-1piperazinyl)ethyl)-2H-benzimidazol-2-one | C20H21F3N4O | PPRRDFIXUUSXRA- UHFFFAOYSA-N |
| 176 | 4-methylpentan-2-amine (DMBA) | 4-methylpentan-2-amine | C6H15N | UNBMPKNTYKDYCG- UHFFFAOYSA-N |
| 177 | Modafinil sulphone | 2-[(diphenylmethyl)sulfonyl]acetamide | C15H15NO3S | ZESNOWZYHYRSRY- UHFFFAOYSA-N |
| 178 | N-methyl aminorex derivative | 3-methyl-5-phenyl-oxazolidin-2-imine | C10H12N2O | PINRUEQFGKWBTO- UHFFFAOYSA-N |
| 179 | 3,4-DMAR | 3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-imine | C11H14N2O | AINPTMZQNYUGDW- UHFFFAOYSA-N |
| 180 | 4-MPH | 3-methyl-2-(4-methylphenyl)morpholine | C12H17NO | NWNCIXFNDVRKE- UHFFFAOYSA-N |
| 181 | Phenetrazine | 3-ethyl-2-phenylmorpholine | C12H17NO | DOMAVIHZFHQQHF- UHFFFAOYSA-N |
| 182 | Epirocaine | 2-methyl-2-(propylamino)propyl benzoate | C14H21NO2 | VXJABHHJLXLNMP- UHFFFAOYSA-N |
| 183 | Modafinil | 2-[(diphenylmethyl)sulfinyl]acetamide | C15H15NO2S | YFGHCGITMMYXAQ- UHFFFAOYSA-N |
| 184 | Iso-phenmetrazine | 5-methyl-2-phenylmorpholine | C11H15NO | LQHGEOIBMBXJGV- UHFFFAOYSA-N |
| 185 | Phenmetetrazine | 4-ethyl-3-methyl-2-phenylmorpholine | C13H19NO | ZOMTUQAEMGCZPK- UHFFFAOYSA-N |
| 186 | 3F-Phenetrazine | 3-ethyl-2-(3-fluorophenyl)morpholine | C12H16FNO | GPTHUZORYIVVNJ- UHFFFAOYSA-N |
| 187 | Bromantane | N-(4-bromophenyl)tricyclo[3.3.1.13,7]decan-2-amine | C16H20BrN | LWJALJDRFBXHKX- UHFFFAOYSA-N |
| 188 | Viloxazine | 2-[(2-ethoxyphenoxy)methyl]morpholine | C13H19NO3 | YWPHCCPCQOJSGZ- UHFFFAOYSA-N |
| 189 | Fladrafinil | 2-([bis(4-fluorophenyl)methyl]sulfinyl)-N-hydroxyacetamide | C15H13F2NO3S | VKGUUSVYPXTWMA- UHFFFAOYSA-N |
| 190 | PDM-35 | 3,5-dimethyl-2-phenylmorpholine | C12H17NO | YKCSYIYQRSVLAK- UHFFFAOYSA-N |
| 191 | 3,6-DMPM | 3,6-dimethyl-2-phenylmorpholine | C12H17NO | FZEIVUHEODGHML- UHFFFAOYSA-N |
| 192 | 3-methylphenmetrazine | 3-methyl-2-(3-methylphenyl)morpholine | C12H17NO | QEDQZYNGDXULGO- UHFFFAOYSA-N |
| 193 | G-130 | 5,5-dimethyl-2-phenyl-morpholine | C12H17NO | KJUOROGOOZJYAI- UHFFFAOYSA-N |
| 194 | Methylmorphenate | methyl 2-(morpholin-3-yl)-2-phenylacetate | C13H17NO3 | FTSNQYGFVFQKHY- UHFFFAOYSA-N |
| 195 | PRE-084 | 2-(morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate | C19H27NO3 | RQHKZUBCUZVZEF- UHFFFAOYSA-N |
| 196 | NDTDI | N,N-diethyl-3-(methyl-[(4R)-1,3,4,5-tetrahydrobenzo[c,d]indol-4yl]amino)propanamide | C19H27N3O | JECGWOMOCPQHDH- UHFFFAOYSA-N |
| 197 | Ru-28306 | N,N-dimethyl-1,3,4,5-tetrahydrobenzo[c,d]indol-4-amine | C13H16N2 | BQOANWOQEHVATQ- UHFFFAOYSA-N |
| 198 | Octodrine | 6-methylheptan-2-amine | C8H19N | QNIVIMYXGGFTAK- UHFFFAOYSA-N |
| 199 | 1,4-DMAA | 5-methylhexan-2-amine | C7H17N | IZCBXLKODYZSDJ- UHFFFAOYSA-N |
| 200 | 2F-Phenmetrazine | 2-(2-fluorophenyl)-3-methylmorpholine | C11H14FNO | QTY LEXQVLJYJ HT- UHFFFAOYSA-N |
| 201 | Troparil | methyl 8-methyl-3-phenyl-8-azabicyclo[3.2.1]octane-4carboxylate | C16H21NO2 | OMBOXYLBBHNWHL- UHFFFAOYSA-N |
| 202 | N-methyl-cyclazodone | 2-[cyclopropyl(methyl)amino]-5-phenyl-4(5H)-oxazolon | C13H14N2O2 | FFWGGFGJVZVGOW- UHFFFAOYSA-N |
| 203 | para-fluoro-4-methylaminorex; 4-FPO | 5-(4-fluorophenyl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine | C10H11FN2O | UYKYWISHPDEDRQ- UHFFFAOYSA-N |
| 204 | Bisfluoromodafinil | 2-([bis(4-fluorophenyl)methyl]sulfinyl)acetamide | C15H13F2NO2S | YEAQNUMCWMRYMU- UHFFFAOYSA-N |
| 205 | WIN 35428 | methyl 3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane2-carboxylate | C16H20FNO2 | QUSLQENMLDRCTO- UHFFFAOYSA-N |
| 206 | alpha-methylephedrine | 3-(methylamino)-2-phenylbutan-2-ol | C11H17NO | SIBUOXVRODUTKZ- UHFFFAOYSA-N |
| 207 | N-methylephedrine | 2-(dimethylamino)-1-phenylpropan-1-ol | C11H17NO | FMCGSUUBYTWNDP- UHFFFAOYSA-N |
| 208 | 1B-LSD | 4-butyryl-N,N-diethyl-7-methyl-4,6,6a,7,8,9- hexahydroindolo[4,3-fg]quinoline-9-carboxamide | C24H31N3O2 | SVRFNPSJPIDUBC- UHFFFAOYSA-N |
| 209 | 2C-B aminorex | 5-(4-bromo-2,5-dimethoxy-phenyl)-4,5-dihydrooxazol-2-amine | C11H13BrN2O3 | XUTCHZHTIDHQOP- UHFFFAOYSA-N |
| 210 | Pagoclone | 2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2oxohexyl)-1H-isoindol-1-one | C23H22ClN3O2 | HIUPRQPBWVEQJJ- UHFFFAOYSA-N |
| 211 | 4-fluorophenibut | 4-amino-3-(4-fluorophenyl)butanoic acid | C10H12FNO2 | QWHXHLDNSXLAPX- UHFFFAOYSA-N |
| 212 | Pregabalin methyl ester | methyl 3-(aminomethyl)-5-methylhexanoate | C9H19NO2 | JDFPGFRTUSUWNI- UHFFFAOYSA-N |
| 213 | Xylazine | N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine | C12H16N2S | BPICBUSOMSTKRF- UHFFFAOYSA-N |
| 214 | SL-164 | 5-chloro-3-(4-chloro-2-methylphenyl)-2-methyl-4(3H)quinazolinone | C16H12Cl2N2O | KUIHLOHNUGOCTO- UHFFFAOYSA-N |
| 215 | 1cP-LSD | 4-(cyclopropanecarbonyl)-N,N-diethyl-7-methyl-4,6,6a,7,8,9hexahydroindolo[4,3-fg]quinoline-9-carboxamide | C24H29N3O2 | RAFUPYYDHPFASC- DYESRHJHSA-N |
| 216 | Nitromethaqualone | 3-(2-methoxy-4-nitrophenyl)-2-methylquinazolin-4-one | C16H13N3O4 | RZHHDMJWDYJXAW- UHFFFAOYSA-N |
| 217 | Nefiracetam | N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide | C14H18N2O2 | NGHTXZCKLWZPGK- UHFFFAOYSA-N |
| 218 | 4-Hydroxyamphetamine | 4-(2-aminopropyl)phenol | C9H13NO | GIKNHHRFLCDOEU - UHFFFAOYSA-N |
| 219 | 25I-NBMD | N-(1,3-benzodioxol-4-ylmethyl)-2-(4-iodo-2,5dimethoxyphenyl)ethanamine | C18H20INO4 | NJNMIPDEUMTYNV - UHFFFAOYSA-N |
| 220 | 25I-NB34MD | N-(1,3-benzodioxol-5-ylmethyl)-2-(4-iodo-2,5dimethoxyphenyl)ethanamine | C18H20INO4 | FWEBGKDUEZRMRQ - UHFFFAOYSA-N |
| 221 | 25C-NBF | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2fluorobenzyl)ethanamine | C17H19ClFNO2 | AHIUIEOLKNDLSC - UHFFFAOYSA-N |
| 222 | 25C-NBOH | 2-(([2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino)methyl)phenol | C17H20ClNO3 | VHWXICYYQMMZCW - UHFFFAOYSA-N |
| 223 | 25I-NBOH | 2-([2-(4-iodo-2,5-dimethoxy-phenyl)ethylamino]methyl)phenol | C17H20INO3 | FEUZHYRXGQTBRO - UHFFFAOYSA-N |
| 224 | 25B-NBF | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2fluorophenyl)methyl]ethanamine | C17H19BrFNO2 | ATMBBMXJNIJRST - UHFFFAOYSA-N |
| 225 | 25B-NBOH | 2-([2-(4-bromo-2,5-dimethoxy- phenyl)ethylamino]methyl)phenol | C17H20BrNO3 | RSUNJYKZRKIBNB - UHFFFAOYSA-N |
| 226 | 1-phenethyl-4-hydroxypiperidine | 1-(2-phenylethyl)piperidin-4-ol | C13H19NO | KYGMSTKBHJVPJK- UHFFFAOYSA-N |
| 227 | 7-CDMeOPPAE | 7-(2-([2-(4-chloro-2,5-dimethoxy-phenyl)-1-methylethyl]amino)ethyl)-1,3-dimethyl-purine-2,6-dione | C20H26ClN5O4 | CWRNNANKXUBLFV- UHFFFAOYSA-N |
| 228 | 25E-NBOH | 2-(([2-(4-ethyl-2,5-dimethoxyphenyl)ethyl]amino)methyl)phenol | C19H25NO3 | SYBINTRPEZWFLZ- UHFFFAOYSA-N |
| 229 | BOD | 2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine | C12H19NO3 | VTEIFHQUZWABDE- UHFFFAOYSA-N |
| 230 | Vanoxerine | 1-(2-[bis(4-fluorophenyl)methoxy]ethyl)-4-(3phenylpropyl)piperazine | C28H32F2N2O | NAUWTFJOPJWYOT- UHFFFAOYSA-N |
| 231 | 1-(3-Methylbenzyl)piperazine | 1-(3-methylbenzyl)piperazine | C12H18N2 | VTEOTZPEMDQENX- UHFFFAOYSA-N |
| 232 | NSI-189 | (4-benzylpiperazin-1-yl)-[2-(isopentylamino)-3- pyridyl]methanone | C22H30N4O | DYTOQURYRYYNOR- UHFFFAOYSA-N |
| 233 | DB-MDBP | 1-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine | C12H14F2N2O2 | MPZINTHEMFDGTH- UHFFFAOYSA-N |
| 234 | 3,4-CFP | 1-(3-chloro-4-fluorophenyl)piperazine | C10H12ClFN2 | MKXFXPRJCBUTLX- UHFFFAOYSA-N |
| 235 | pBPP | 1-(4-bromophenyl)piperazine | C10H13BrN2 | PJHPFAFEJNBIDC- UHFFFAOYSA-N |
| 236 | HDMP-28 (methylnaphthidate) | methyl naphthalen-2-yl(piperidin-2-yl)acetate | C18H21NO2 | DNRNSIJBSCBESJ- UHFFFAOYSA-N |
| 237 | Propylphenidate | propyl phenyl(piperidin-2-yl)acetate | C16H23NO2 | PRMWWEANNQSWAR- UHFFFAOYSA-N |
| 238 | 4-fluoroethylphenidate | ethyl 2-(4-fluorophenyl)-2-(2-piperidyl)acetate | C15H20FNO2 | RKXQYWFDJDYSEN- UHFFFAOYSA-N |
| 239 | methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate | methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate | C13H17NO2 | NVTLFQBLMSATNO- UHFFFAOYSA-N |
| 240 | Glaucine | 1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4Hdibenzo[de,g]quinoline | C21H25NO4 | RUZIUYOSRDWYQF- UHFFFAOYSA-N |
| 241 | LSA | (6aS,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3fg]quinoline-9-carboxamide | C16H17N3O | GENAHGKEFJLNJB- HZMBPMFUSA-N |
| 242 | Arecoline | methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate | C8H13NO2 | HJJPJSXJAXAIPN- UHFFFAOYSA-N |
| 243 | 5-Br-DMT | [2-(5-bromo-1H-indol-3-yl)ethyl]dimethylamine | C12H15BrN2 | ATEYZYQLBQUZJE- UHFFFAOYSA-N |
| 244 | 5-Cl-DMT | [2-(5-chloro-1H-indol-3-yl)ethyl]dimethylamine | C12H15ClN2 | LXATUVRMTAHHDX- UHFFFAOYSA-N |
| 245 | Mephedrene | N-methyl-1-(5-methyl-2-thiophenyl)propan-2-amine | C9H15NS | HZICDJQMPRFRKC- UHFFFAOYSA-N |
| 246 | PTI-3 | N-((2-[1-(5-fluoropentyl)-1H-indol-3-yl]-1,3-thiazol-4-yl)methyl)2-methoxy-N-methylethan-1-amine | C21H28FN3OS | LXQIIHJBHSFWQW- UHFFFAOYSA-N |
| 247 | Cumyl-Cb-MeGaClone | 5-(cyclobutylmethyl)-2-(1-methyl-1-phenyl-ethyl)pyrido[4,3b]indol-1-one | C25H26N2O | VOCGZWPYRQJUMY- UHFFFAOYSA-N |
| 248 | BOH-2C-B | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanol | C10H14BrNO3 | PCSKDXWCLQXURQ- UHFFFAOYSA-N |
| 249 | N-methylbenzedrone | 2-[benzyl(methyl)amino]-1-(4-methylphenyl)propan-1-one | C18H21NO | UIOKRZKDMRJWFG- UHFFFAOYSA-N |
| 250 | 3F-PCP | 1-[1-(3-fluorophenyl)cyclohexyl]piperidine | C17H24FN | PFPLGKFWWBXTNP- UHFFFAOYSA-N |
| 251 | 3-Cl-PCP | 1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine | C17H24ClN | HUHBTESMMFLCAN- UHFFFAOYSA-N |
| 252 | A-D2PV (alpha-pyrrolidino-2phenylacetophenone, alpha-D2PV) | 1,2-diphenyl-2-(pyrrolidin-1-yl)ethan-1-one | C18H19NO | GQCCTZGWWWUYLS- UHFFFAOYSA-N |
| 253 | 3-Me-PCP | 1-[1-(3-methylphenyl)cyclohexyl]piperidine | C18H27N | BMFKUCGCXMDGBK- UHFFFAOYSA-N |
| 254 | MXiPR (methoxisopropamine) | 2-(isopropylamino)-2-(3-methoxyphenyl)-cyclohexanone | C16H23NO2 | FTQIVDGNGXPEKP- UHFFFAOYSA-N |
| 255 | Cumyl-BC-HpMeGaClone-221 | 5-(bicyclo[2.2.1]hept-2-ylmethyl)-2-(2-phenylpropan-2-yl)-2,5dihydro-1H-pyrido[4,3-b]indol-1-one | C28H30N2O | VFBNNQOHBYEVLU- UHFFFAOYSA-N |
| 256 | 3-Methoxyphenmetrazine | 2-(3-methoxyphenyl)-3-methylmorpholine | C12H17NO2 | QKAKYFBKVKSLLT- UHFFFAOYSA-N |
| 257 | butonitazene | 2-[2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl]-N,Ndiethylethan-1-amine | C24H32N4O3 | UZZPOLCDCVWLAZ- UHFFFAOYSA-N |
| 258 | etonitazepyne | 2-(4-ethoxybenzyl)-5-nitro-1-[2-(pyrrolidin-1-yl)ethyl]-1Hbenzimidazole | C22H26N4O3 | LQZWZCJCEPUKCJ- UHFFFAOYSA-N |
| 259 | BDMT | 2,2’-(1H,1’H-[2,2’-biindole]-3,3’-diyl)bis(N,N-dimethylethan-1amine) | C24H30N4 | LDSNARXIXVOSTN- UHFFFAOYSA-N |
| 260 | ABO-4en-PINACA | N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3carboxamide | C17H22N4O2 | SHELRBQJCJWWQC- UHFFFAOYSA-N |
| 261 | 4F-deprenyl | N-[1-(4-fluorophenyl)propan-2-yl]-N-methylprop-2-yn-1-amine | C13H16FN | MUDUXRHPVDVWHU- UHFFFAOYSA-N |
| 262 | fluonitazene | N,N-diethyl-2-[2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1yl]ethan-1-amine | C20H23FN4O2 | ZTWHIDCAGRMKTC- UHFFFAOYSA-N |
| 263 | M-alpha-HCMA | 3-(1,3-benzodioxol-5-yl)-2-hydroxy-N,2-dimethyl-3(methylamino)propanamide | C13H18N2O4 | GGNDZIOJQYAARA- UHFFFAOYSA-N |
| 264 | AP-238 | 1-[2,6-dimethyl-4-(3-phenylprop-2-enyl)piperazin-1-yl]propan1-one | C18H26N2O | JELNWDOXWGBBLO- UHFFFAOYSA-N |
| 265 | carbonyl-bromadol | (4-bromophenyl)-[1-(dimethylamino)-4-hydroxy-4phenethylcyclohexyl]methanone | C23H28BrNO2 | SQKVCASVOTZNCS- UHFFFAOYSA-N |
| 266 | O-AMKD | 3-(4-acetyl-1-methylpiperidin-4-yl)phenyl acetate | C16H21NO3 | ZXPASXBVYVTLRG- UHFFFAOYSA-N |
| 267 | nortilidine | ethyl 2-methylamino-1-phenylcyclohex-3-ene-1-carboxylate | C16H21NO2 | PDJZPNKVLDWEKI- UHFFFAOYSA-N |
| 268 | 4,4-dimethyl-1-phenyl-1-pyrrolidin-1-ylpentan-3-one | 4,4-dimethyl-1-phenyl-1-pyrrolidin-1-yl-pentan-3-one | C17H25NO | JZBYSJKUYKWHMX- UHFFFAOYSA-N |
| 269 | phenylpiracetam | 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide | C12H14N2O2 | LYO NXVJ RBWWG QO- UHFFFAOYSA-N |
| 270 | deoxymethoxetamine | 2-(ethylamino)-2-(3-methylphenyl)-cyclohexanone | C15H21NO | WIMLPRYZJQNQLE- UHFFFAOYSA-N |
| 271 | CHM-MDMB-CHMINACA | cyclohexylmethyl 2-[1-(cyclohexylmethyl)-1H-indazole-3carboxamido]-3,3-dimethylbutanoate | C28H41N3O3 | BJNHBUMERXHSSM- UHFFFAOYSA-N |
| 272 | protonitazene | N,N-diethyl-5-nitro-2-[(4-propoxyphenyl)methyl]-1Hbenzimidazole-1-ethanamine | C23H30N4O3 | SJHUJFHOXYDSJY- UHFFFAOYSA-N |
| 273 | 4Br-MAR (para-bromo-4-methylaminorex) | 5‐(4‐bromophenyl)‐4‐methyl‐4,5‐dihydro‐1,3‐oxazol‐2‐amine | C10H11BrN2O | TUHDNALAVIDYHT- UHFFFAOYSA-N |
| 274 | 4Cl-MAR (Para-chloro-4-methylaminorex) | 5‐(4‐chlorophenyl)‐4‐methyl‐4,5‐dihydro‐1,3‐oxazol‐2‐amine | C10H11ClN2O | PEMJVPLFSLEVII-UHFFFAOYSA-N |
| 275 | 2C-T-21 | 2-[4-(2-fluoroethylsulfanyl)-2,5-dimethoxy-phenyl]ethanamine | C12H18FNO2S | ZBUUUKBTOCTOPW- UHFFFAOYSA-N |
| 276 | 5-chloro-alpha MT (5-Chloro-alphamethyltryptamine) | 1‐(5‐chloro‐1H‐indol‐3‐yl)propan‐2‐amine | C11H13ClN2 | QMKOQSCXSYPIPB- UHFFFAOYSA-N |
| 277 | 3-chlorophenmetrazine; 3-CPM | 2-(3-chlorophenyl)-3-methylmorpholine | C11H14ClNO | BOFUZZAQNVYZFF- UHFFFAOYSA-N |
| 278 | Hydroxetamine; HXE | 2-(ethylamino)-2-(3-hydroxyphenyl)-cyclohexanone | C14H19NO2 | CQERUJSORROCGH- UHFFFAOYSA-N |
| 279 | Dipyanone | 4,4-diphenyl-6-(pyrrolidin-1-yl)heptan-3-one | C23H29NO | LJIUPFDRFKFNJE- UHFFFAOYSA-N |
| 280 | Bretazenil | 1,1-dimethylethyl 8-bromo-11,12,13,13a-tetrahydro-9-oxo-9Himidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate | C19H20BrN3O3 | LWUDDYHYYNNIQI- UHFFFAOYSA-N |
| 281 | Deschloroclotizolam | 2-chloro-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3a][1,4]diazepine | C15H11ClN4S | DBAZIULAFZCKIM- UHFFFAOYSA-N |
| 282 | BZO-POXIZID (MDA-19 pentyl analogue) | N-[(Z)-(2-oxo-1-pentyl-indolin-3-ylidene)amino]benzamide | C20H21N3O2 | PCHOEXVGYICASA- UZYVYHOESA-N |
| 283 | iso-3-CMC | 1-(3-chlorophenyl)-1-(methylamino)propan-2-one | C10H12ClNO | CRNFRDNGAHBKFB- UHFFFAOYSA-N |
| 284 | BZO-4en-POXIZID (MDA-19 4en-pentyl analogue) | N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-ylidene)amino]benzamide | C20H19N3O2 | DIVZUDBOOCSMQO- UZYVYHOESA-N |
| 285 | ADB-5Br-INACA | 5-bromo-N-(1-carbamoyl-2,2-dimethyl-propyl)-1H-indazole-3carboxamide | C14H17BrN4O2 | AJGASUCDTSLMNP- UHFFFAOYSA-N |
| 286 | BZO-ChMOXIZID | N-((Z)-[1-(cyclohexylmethyl)-2-oxo-indolin-3ylidene]amino)benzamide | C22H23N3O2 | HTPDZRIIOLCPPS- ATJXCDBQSA-N |
| 287 | 3,5-ADB-4en-PFUPPYCA | N-(1-carbamoyl-2,2-dimethyl-propyl)-3-(4-fluorophenyl)-1-pent4-enyl-pyrazole-5-carboxamide | C21H27FN4O2 | JPCQBOGNKSMAIE- UHFFFAOYSA-N |
| 288 | desmethylmoramide | 4-(4-morpholinyl)-2,2-diphenyl-1-(1-pyrrolidinyl)-1-butanone | C24H30N2O2 | JRPANCYSRUEJDY- UHFFFAOYSA-N |
| 289 | ADB-FUBIATA (ADB-FUBIACA) | 2-[(2-(1-[(4-fluorophenyl)methyl]indol-3-yl)acetyl)amino]-3,3dimethyl-butanamide | C23H26FN3O2 | KHAUCCNSUMBFOT- UHFFFAOYSA-N |
| 290 | 5F-BZO-POXIZID; 5F-MDA-19; MDA-19 5-fluoropentyl analogue | N-((Z)-[1-(5-fluoropentyl)-2-oxo-indolin-3- ylidene]amino)benzamide | C20H20FN3O2 | CJINBVDNZDUMJM- PYCFMQQDSA-N |
| 291 | 3-Me-PCPy | 1-[1-(3-methylphenyl)cyclohexyl]pyrrolidine | C17H25N | JZVMREFYFTZXGN- UHFFFAOYSA-N |
| 292 | flubrotizolam | 2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno [3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | C15H10BrFN4S | VOZDBDBHBXLWCG- UHFFFAOYSA-N |
| 293 | 5,3-ADB-4en-PFUPPYCA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-(4-fluorophenyl)-1pent-4-enyl-pyrazole-3-carboxamide | C21H27FN4O2 | WGRQGKCMZJBNQD- UHFFFAOYSA-N |
| 294 | 5,3-AB-CHMFUPPYCA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-5(4-fluorophenyl)-1H-pyrazole-3-carboxamide | C22H29FN4O2 | XMZXGVYPIIOHAQ- UHFFFAOYSA-N |
| 295 | fenozolone | 2-(ethylamino)-5-phenyl-4(5H)-oxazolone | C11H12N2O2 | RXOIEVSUURELPG- UHFFFAOYSA-N |
| 296 | CUMYL-TsINACA | N-(2-phenylpropan-2-yl)-1-tosyl-1H-indazole-3-carboxamide | C24H23N3O3S | NZHIGLHQWQLPPC- UHFFFAOYSA-N |
| 297 | 1V-LSD | N,N-diethyl-7-methyl-4-pentanoyl-4,6,6a,7,8,9hexahydroindolo[4,3-fg]quinoline-9-carboxamide | C25H33N3O2 | GIIBVGJWUZNECE- XMSQKQJNSA-N |
| 298 | etonitazepipne | 2-(4-ethoxybenzyl)-5-nitro-1-[2-(piperidin-1-yl)ethyl]-1Hbenzo[d]imidazole | C23H28N4O3 | UMGXRAISFRUVKD- UHFFFAOYSA-N |
| 299 | iso-(meta-methyl-propcathinone) | 1-(3-methylphenyl)-1-(propylamino)propan-2-one | C13H19NO | UPNWYTPGWJZSBN- UHFFFAOYSA-N |
| 300 | N-benzyl-isopropylamine | N-benzylpropan-2-amine | C10H15N | LYBKPDDZTNUNNM- UHFFFAOYSA-N |
| 301 | ADB-IACA (ADB-IATA) | 2-[2-(1H-indol-3-yl)acetamido]-3,3-dimethylbutanamide | C16H21N3O2 | WUWCLBKDNAZHPN- UHFFFAOYSA-N |
| 302 | Cumyl-INACA | N-(1-methyl-1-phenyl-ethyl)-1H-indazole-3-carboxamide | C17H17N3O | COOPWWXIRLDJCP- UHFFFAOYSA-N |
| 303 | Cumyl-CHSINACA | 1-(cyclohexylsulfonyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3carboxamide | C23H27N3O3S | ZNRPDVCQZGICAF- UHFFFAOYSA-N |
| 304 | Cumyl-CLCHSINACA (CUMYL-1ClCHSINACA) | 1-(1-chlorocyclohexyl)sulfonyl-N-(1-methyl-1-phenylethyl)indazole-3-carboxamide | C23H26ClN3O3S | MNMREJDPBHYPIR- UHFFFAOYSA-N |
| 305 | CH-FUBIACA | N-cyclohexyl-2-[1-(4-fluorobenzyl)-1H-indol-3-yl]acetamide | C23H25FN2O | GSTACBDFNQHWHP- UHFFFAOYSA-N |
| 306 | CH-PIACA | N-cyclohexyl-2-(1-pentyl-1H-indol-3-yl)acetamide | C21H30N2O | SYYOOLIGHZEOKJ- UHFFFAOYSA-N |
| 307 | MDMB-5Br-INACA | methyl 2-(5-bromo-1H-indazole-3-carboxamido)-3,3- dimethylbutanoate | C15H18BrN3O3 | QGEVEXPJOKFMAN- UHFFFAOYSA-N |
| 308 | ADB-D-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-decyl-1Hindazole-3-carboxamide | C24H37BrN4O2 | YDOQIEUYWRSIGV- UHFFFAOYSA-N |
| 309 | A-PONASA | N-(adamantan-1-yl)-4-(pentyloxy)naphthalene-1- sulfonamide | C25H33NO3S | KDLJELWGBJUNBO- UHFFFAOYSA-N |
| 310 | fluetizolam | 2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine | C17H15FN4S | BCKPHENWWQCRCG- UHFFFAOYSA-N |
| 311 | ADB-4en-P-5Br-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-(pent-4en-1-yl)-1H-indazole-3-carboxamide | C19H25BrN4O2 | SKMMFULKOGGVOT- UHFFFAOYSA-N |
| 312 | Desalkylgidazepam | 7-bromo-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | C15H11BrN2O | ATCCWKYKHCKDGT- UHFFFAOYSA-N |
| 313 | N-cyclohexyl methylone | 1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one | C16H21NO3 | WZDQUORQDHVTKD- UHFFFAOYSA-N |
| 314 | N-ethyl zolpidem | N-ethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3yl]acetamide | C19H21N3O | GQJSOTATHCNTSW- UHFFFAOYSA-N |
| 315 | 2-fluoro-deschloro-N-ethylketamine | 2-(ethylamino)-2-(2-fluorophenyl)cyclohexanone | C14H18FNO | RTXKYSLDFKUESF- UHFFFAOYSA-N |
| 316 | A-FUBIACA | N-(1-adamantyl)-2-[1-[(4-fluorophenyl)methyl]indol-3yl]acetamide | C27H29FN2O | UGPWISFILITTLX- UHFFFAOYSA-N |
| 317 | hexahydrocannabinol (HHC) | 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol | C₂₁H₃₂O₂ | XKRHRBJLCLXSGE- UHFFFAOYSA-N |
| 318 | 4en-PDMB-4en-PINACA | pent-4-en-1-yl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3carboxamido)-butanoate | C₂₄H₃₃N₃O₃ | CQZNZGBBRCLQTI- UHFFFAOYSA-N |
| 319 | Acetyl-hexahydrocannabinol (HHC acetate) | (6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10ahexahydrobenzo[c]chromen-1-yl) acetate | C₂₃H₃₄O₃ | ZAZIHGFBNRVMAI- UHFFFAOYSA-N |
| 320 | Hexahydrocannabiphorol (HHC-P) | 3-Heptyl-6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-6Hdibenzo[b,d]pyran-1-ol | C₂₃H₃₆O₂ | USZILQYXSONCHH- UHFFFAOYSA-N |
| 321 | Fluorexetamine (FXE) | 2-(ethylamino)-2-(3-fluorophenyl)cyclohexan-1-one | C₁₄H₁₈FNO | FCETYWCLCUZFJI- UHFFFAOYSA-N |
| 322 | Rilmazafone | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2chlorobenzoyl)phenyl]-N,N-dimethyl-1H-1,2,4-triazole-3carboxamide | C₂₁H₂₀Cl₂N₆O₃ | KYHFRCPLIGODFH- UHFFFAOYSA-N |
| 323 | 5-MeO-TMT | 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N,N-dimethylethanamine | C₁₄H₂₀N₂O | ACEHBQPPDDGCGZ- UHFFFAOYSA-N |
| 324 | ADMB-INACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3carboxamide | C₁₄H₁₈N₄O₂ | UFECWXZSRFBSHC- UHFFFAOYSA-N |
| 325 | FUBIAT | 1-[(4-fluorophenyl)methyl]-1H-indole-3-acetic acid | C₁₇H₁₄FNO₂ | MSECUWYFWKAGLD- UHFFFAOYSA-N |
| 326 | 4F-MBZP | 1-[(4-fluorophenyl)methyl]-4-methylpiperazine | C₁₂H₁₇FN₂ | KFMDNJJTGINMCS- UHFFFAOYSA-N |
"
2. Az R. 3. melléklete a következő 7. ponttal egészül ki:
"7. A jegyzékbe sorolás szempontjából a 6.1. pontban foglalt táblázat A és B oszlopában található adatok irányadóak, a C és D oszlop adatai a vegyületek számítógépes kereshetőségét biztosítják."